US20110160762A1 - Apparatus and methods for reducing embolization during treatment of carotid artery disease - Google Patents
Apparatus and methods for reducing embolization during treatment of carotid artery disease Download PDFInfo
- Publication number
- US20110160762A1 US20110160762A1 US13/043,402 US201113043402A US2011160762A1 US 20110160762 A1 US20110160762 A1 US 20110160762A1 US 201113043402 A US201113043402 A US 201113043402A US 2011160762 A1 US2011160762 A1 US 2011160762A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- blood
- emboli
- balloon
- flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
- A61B17/12045—Type of occlusion temporary occlusion double occlusion, e.g. during anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/0105—Open ended, i.e. legs gathered only at one side
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B2017/320716—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions comprising means for preventing embolism by dislodged material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2217/00—General characteristics of surgical instruments
- A61B2217/002—Auxiliary appliance
- A61B2217/005—Auxiliary appliance with suction drainage system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/011—Instruments for their placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
- A61M2025/0681—Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09008—Guide wires having a balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09175—Guide wires having specific characteristics at the distal tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
- A61M2025/1015—Multiple balloon catheters having two or more independently movable balloons where the distance between the balloons can be adjusted, e.g. two balloon catheters concentric to each other forming an adjustable multiple balloon catheter system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/109—Balloon catheters with special features or adapted for special applications having balloons for removing solid matters, e.g. by grasping or scraping plaque, thrombus or other matters that obstruct the flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1097—Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation only while the balloon is in an inflated state, e.g. temporary by-pass within balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
Definitions
- This invention relates to apparatus and methods for protecting against embolization during vascular interventions, such as carotid artery angioplasty and endarterectomy. More particularly, the apparatus and methods of the present invention induce substantially continuous retrograde flow through the internal carotid artery during treatment during an interventional procedure, without significant blood loss.
- Carotid artery stenoses typically manifest in the common carotid artery, internal carotid artery or external carotid artery as a pathologic narrowing of the vascular wall, for example, caused by the deposition of plaque, that inhibits normal blood flow.
- Endarterectomy an open surgical procedure, traditionally has been used to treat such stenosis of the carotid artery.
- emboli may be formed during the course of the procedure, and these emboli can rapidly pass into the cerebral vasculature and cause ischemic stroke.
- Such emboli may be created, for example, when an interventional instrument, such as a guide wire or angioplasty balloon, is forcefully passed into or through the stenosis, as well as after dilatation and deflation of the angioplasty balloon or stent deployment. Because such instruments are advanced into the carotid artery in the same direction as blood flow, emboli generated by operation of the instruments are carried directly to the brain by antegrade blood flow. Stroke rates after carotid artery stenting have widely varied in different clinical series, from as low as 4.4% to as high as 30%.
- carotid artery stenting including data from twenty-four major interventional centers in Europe, North America, South America and Asia, had a combined initial failure and combined mortality/stroke rate of more than 7%.
- Cognitive studies and reports of intellectual changes after carotid artery stenting indicate that embolization is a common event causing subclinical cerebral damage.
- Solano et al. U.S. Pat. No. 4,921,478 describes cerebral angioplasty methods and devices wherein two concentric shafts are coupled at a distal end to a distally-facing funnel-shaped structure.
- a lumen of the innermost shaft communicates with an opening in the funnel-shaped structure at the distal end, and is open to atmospheric pressure at the proximal end.
- the funnel-shaped structure is deployed proximally (in the direction of flow) of a stenosis, occluding antegrade flow.
- An angioplasty balloon catheter is passed through the innermost lumen and into the stenosis, and then inflated to dilate the stenosis.
- the patent states that when the angioplasty balloon is deflated, a pressure differential between atmospheric pressure and the blood distal to the angioplasty balloon causes a reversal of flow in the vessel that flushes any emboli created by the angioplasty balloon through the lumen of the innermost catheter.
- Applicant has determined another drawback of the method described in the Solano patent: deployment of the funnel-shaped structure in the common carotid artery (“CCA”) causes reversal of flow from the external carotid artery (“ECA”) into the internal carotid artery (“ICA”). Consequently, when a guide wire or interventional instrument is passed across a lesion in either the ECA or ICA, emboli dislodged from the stenosis are introduced into the blood flow and carried into the cerebral vasculature via the ICA.
- CCA common carotid artery
- ICA internal carotid artery
- EP Publication No. 0 427 429 describes use of a separate balloon to occlude the ECA prior to crossing the lesion in the ICA.
- that publication discloses that flow reversal occurs only when the dilatation balloon in the ICA is deflated.
- the occlusion balloons on the guide catheter and in the ECA are inflated to block antegrade blood flow to the brain.
- the dilation balloon then is deflated, the dilation catheter is removed, and blood is aspirated from the ICA to remove emboli.
- the occlusion balloons are not inflated until after inflation of the dilation balloon. Microemboli generated during advancement of the dilation catheter into the stenosed segment may therefore be carried by antegrade blood flow into the brain before dilation, occlusion, and aspiration are even attempted.
- Imran U.S. Pat. No. 5,833,650 describes a system for treating stenoses that comprises three concentric shafts.
- the outermost shaft includes a proximal balloon at its distal end that is deployed proximal of a stenosis to occlude antegrade blood flow.
- a suction pump then draws suction through a lumen in the outermost shaft to cause a reversal of flow in the vessel while the innermost shaft is passed across the stenosis.
- a distal balloon on the innermost shaft is deployed to occlude flow distal to the stenosis.
- Autologous blood taken from a femoral artery using an extracorporeal blood pump is infused through a central lumen of the innermost catheter to provide continued antegrade blood flow distal to the distal balloon.
- the third concentric shaft which includes an angioplasty balloon, is then advanced through the annulus between the innermost and outermost catheters to dilate the stenosis.
- the device of the Imran patent appears to suffer the drawback of potentially dislodging emboli that are carried into the cerebral vasculature.
- flow reversal in the vasculature distal to the distal balloon ceases, and the blood perfused through the central lumen of the innermost shaft establishes antegrade flow.
- emboli are generated during deployment of the distal balloon, those emboli will be carried by the perfused blood directly into the cerebral vasculature, and again pose a risk of ischemic stroke.
- reperfusion of blood under pressure through a small diameter catheter may contribute to hemolysis and possible dislodgment of emboli.
- emboli removal systems it would be desirable to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that reduce the risk that emboli are carried into the cerebral vasculature.
- emboli removal methods and apparatus that prevent the development of reverse flow from the ECA and antegrade into the ICA once the CCA has been occluded, thereby enhancing the likelihood that emboli generated by a surgical or interventional procedure are effectively removed from the vessel.
- interventional apparatus comprising an arterial catheter, an occlusion element disposed on a guide wire, a venous return sheath, and optionally a blood filter.
- the arterial catheter has proximal and distal ends, an aspiration lumen extending therethrough, an occlusion element disposed on the distal end, and a hemostatic port and blood outlet port disposed on the proximal end that communicate with the aspiration lumen.
- the aspiration lumen is sized so that an interventional instrument, e.g., an angioplasty catheter or stent delivery system, may be readily advanced therethrough to the site of a stenosis in either the ECA (proximal to the occlusion element) or the ICA.
- an interventional instrument e.g., an angioplasty catheter or stent delivery system
- the arterial catheter is disposed in the CCA proximal of the ICA/ECA bifurcation, the occlusion element on the guide wire is disposed in the ECA to occlude flow reversal from the ECA to the ICA, and the blood outlet port of the arterial catheter is coupled to the venous return sheath, with or without the blood filter disposed therebetween.
- Higher arterial than venous pressure permits substantially continuous flow reversal in the ICA during the procedure (other than when a dilatation balloon is inflated), thereby flushing blood containing emboli from the vessel.
- the blood is filtered and reperfused into the body through the venous return sheath.
- the occlusion element disposed on the guide wire may be omitted, and replaced with apparatus comprising a self-expanding element having proximal and distal ends, a retrieval wire coupled to the proximal end and an atraumatic tip coupled to the distal end.
- a dilator having a lumen may be disposed within the aspiration lumen of the catheter so that the occlusion element is provided in a contracted state within the lumen of the dilator. The occlusion element then is ejected from the dilator and self-expands to occlude the ECA.
- the dilator then is removed from the aspiration lumen of the catheter, and the distal end of the catheter is re-positioned in the CCA proximal of the carotid bifurcation.
- Flow reversal is induced in the ICA, as described above, and the self-expanding occlusion element may be contracted using the retrieval wire provided.
- FIGS. 1A and 1B are schematic views of previously known emboli protection systems
- FIG. 2 is a schematic view of an emboli protection system in accordance with principles of the present invention.
- FIGS. 3A-3D are, respectively, a schematic view of apparatus in accordance with a first embodiment of the present invention, detailed side and sectional views of the distal end of an interventional device of the present invention, and a cross-sectional view of an interventional device of the present invention;
- FIGS. 4A and 4B are views of the distal end of an alternative interventional device suitable for use in the system of the present invention.
- FIGS. 5A-5D illustrate a method of using the system of FIG. 3 in accordance with the principles of the present invention
- FIGS. 6A-6C are, respectively, a schematic view and cross-sectional views of the proximal and distal ends of a catheter of an alternative embodiment of the present invention.
- FIGS. 7A-7B depict features of the self-expanding occlusion element of FIG. 6 ;
- FIGS. 8A-8D illustrate a method of using the system of FIG. 6 in accordance with the principles of the present invention.
- FIGS. 1A and 1B drawbacks of previously known emboli removal catheters are described with reference to performing percutaneous angioplasty of stenosis S in common carotid artery CCA.
- FIG. 1A drawbacks associated with naturally-aspirated emboli removal systems, such as described in the above-mentioned patent to Solano and European Patent Publication, are described. No flow reversal is induced by those systems until after balloon 10 of angioplasty catheter 11 first is passed across the stenosis, inflated, and then deflated. However, applicant has determined that once member 15 of emboli removal catheter 16 is inflated, flow within the ECA reverses and provides antegrade flow into the ICA, due to the lower hemodynamic resistance of the ICA.
- emboli E generated while passing guide wire 20 or catheter 11 across stenosis S may be carried irretrievably into the cerebral vasculature, before flow in the vessel is reversed and directed into the aspiration lumen of emboli removal catheter 16 by opening the proximal end of the aspiration lumen to atmospheric pressure.
- natural-aspiration may not remove an adequate volume of blood to retrieve even those emboli that have not yet been carried all the way into the cerebral vasculature.
- FIG. 1B system 17 described in the above-mentioned patent to Imran is shown.
- deployment of distal balloon 18 , and ejection of blood out of the distal end of the inner catheter may dislodge emboli from the vessel wall distal to balloon 18 .
- the introduction of antegrade flow through inner catheter 19 is expected only to exacerbate the problem by pushing the emboli further into the cerebral vasculature.
- the use of positive suction in the Imran system may remove emboli located in the confined treatment field defined by the proximal and distal balloons, such suction is not expected to provide any benefit for emboli dislodged distal of distal balloon 18 .
- Apparatus 30 comprises catheter 31 having an aspiration lumen and occlusion element 32 , and guide wire 35 having inflatable balloon 36 disposed on its distal end.
- catheter 31 having an aspiration lumen and occlusion element 32
- guide wire 35 having inflatable balloon 36 disposed on its distal end.
- antegrade blood flow is stopped when both occlusion element 32 in the CCA and inflatable balloon 36 are deployed.
- the aspiration lumen of catheter 31 is connected to a venous return sheath (described hereinbelow), disposed, for example, in the patient's femoral vein. In this manner a substantially continuous flow of blood is induced between the treatment site and the patient's venous vasculature. Because flow through the artery is towards catheter 31 , any emboli dislodged by advancing a guide wire or angioplasty catheter 33 across stenosis S causes the emboli to be aspirated by catheter 31 .
- the present invention provides substantially continuous retrograde blood flow through the ICA while preventing blood from flowing retrograde in the ECA and antegrade into the ICA, thereby preventing emboli from being carried into the cerebral vasculature. Because the apparatus and methods of the present invention “recycle” emboli-laden blood from the arterial catheter through the blood filter and to the venous return sheath, the patient experiences significantly less blood loss.
- Apparatus 40 constructed in accordance with the principles of the present invention is described.
- Apparatus 40 comprises arterial catheter 41 , guide wire 45 , venous return sheath 52 , tubing 49 and optional blood filter 50 .
- Catheter 41 includes distal occlusion element 42 , proximal hemostatic port 43 , e.g., a Touhy-Borst connector, inflation port 44 , and blood outlet port 48 .
- Guide wire 45 includes balloon 46 that is inflated via inflation port 47 .
- Tubing 49 couples blood outlet port 48 to filter 50 and blood inlet port 51 of venous return sheath 52 .
- Guide wire 45 and balloon 46 are configured to pass through hemostatic port 43 and the aspiration lumen of catheter 41 (see FIGS. 3C and 3D ), so that the balloon may be advanced into and occlude the ECA.
- Port 43 and the aspiration lumen of catheter 41 are sized to permit additional interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through the aspiration lumen when guide wire 45 is deployed.
- Guide wire 45 preferably comprises a small diameter flexible shaft having an inflation lumen that couples inflatable balloon 46 to inflation port 47 .
- Inflatable balloon 46 preferably comprises a compliant material, such as described hereinbelow with respect to occlusion element 42 of emboli removal catheter 41 .
- Venous return sheath 52 includes hemostatic port 53 , blood inlet port 51 and a lumen that communicates with ports 53 and 51 and tip 54 .
- Venous return sheath 52 may be constructed in a manner per se known for venous introducer catheters.
- Tubing 49 may comprise a suitable length of a biocompatible material, such as silicone.
- tubing 49 may be omitted and blood outlet port 48 of catheter 41 and blood inlet port 51 of venous return sheath 52 may be lengthened to engage either end of filter 50 or each other.
- distal occlusion element 42 comprises expandable bell or pear-shaped balloon 55 .
- balloon 55 comprises a compliant material, such as polyurethane, latex or polyisoprene which has variable thickness along its length to provide a bell-shape when inflated.
- Balloon 55 is affixed to distal end 56 of catheter 41 , for example, by gluing or a melt-bond, so that opening 57 in balloon 55 leads into aspiration lumen 58 of catheter 41 .
- Balloon 55 preferably is wrapped and heat treated during manufacture so that distal portion 59 of the balloon extends beyond the distal end of catheter 41 and provides an atraumatic tip or bumper for the catheter.
- catheter 41 preferably comprises inner layer 60 of low-friction material, such as polytetrafluoroethylene (“PTFE”), covered with a layer of flat stainless steel wire braid 61 and polymer cover 62 (e.g., polyurethane, polyethylene, or PEBAX).
- Inflation lumen 63 is disposed within polymer cover 62 and couples inflation port 44 to balloon 55 .
- the diameter of lumen 58 is about 7 Fr, and the outer diameter of the catheter is about 9 Fr.
- occlusion element 42 of emboli removal catheter 41 comprises self-expanding wire basket 65 covered with elastomeric polymer 66 , such as latex, polyurethane or polyisoprene.
- elastomeric polymer 66 such as latex, polyurethane or polyisoprene.
- a tightly knit self-expanding wire mesh may be used, with or without an elastomeric covering.
- Catheter 41 is contained within movable sheath 67 .
- Catheter 41 is inserted transluminally with sheath 67 in a distalmost position, and after basket 65 has been determined to be in a desired position proximal to a stenosis, sheath 67 is retracted proximally to cause basket 65 to deploy.
- basket 65 is again collapsed within sheath 67 by moving the sheath to its distalmost position. Operation of the system of FIG. 3A using the emboli removal catheter of FIGS. 4A and 4B is similar to that described hereinbelow for FIGS. 5A-5D , except that the occlusion element self-expands when sheath 67 is retracted, rather than by infusing an inflation medium to balloon 55 .
- stenosis S is located in internal carotid artery ICA above the bifurcation between the ICA and the external carotid artery ECA.
- guide wire 80 is inserted into a patient's arterial vasculature and a distal end of guide wire 80 preferably is disposed just proximal of the carotid bifurcation, as shown in FIG. 5A .
- a dilator (not shown), which is disposed within catheter 41 , then may be inserted over guide wire 80 to advance catheter 41 to a position proximal of stenosis S, as shown in FIG. 5A , and the dilator may be removed.
- Balloon 55 of distal occlusion element 42 then is inflated via inflation port 44 , preferably using a radiopaque contrast solution, and guide wire 80 may be removed. Once balloon 55 of distal occlusion element 42 is inflated, flow within the ECA reverses and provides antegrade flow into the ICA, as shown in FIG. 5A , due to the lower hemodynamic resistance of the ICA.
- Venous return sheath 52 then is introduced into the patient's femoral vein, either percutaneously or via a surgical cut-down.
- Filter 50 then is coupled between blood outlet port 48 of catheter 41 and blood inlet port 51 of venous return sheath 52 using tubing 49 , and any air is removed from the line. Once this circuit is closed, negative pressure in the venous sheath during diastole will establish a low rate continuous flow of blood through aspiration lumen 58 of catheter 41 , to the patient's vein via venous return sheath 52 .
- Guide wire 45 and balloon 46 then may be advanced through aspiration lumen 58 .
- balloon 46 When balloon 46 is disposed within the ECA, as determined, e.g., using a fluoroscope and a radiopaque inflation medium injected into balloon 46 , balloon 46 is inflated. The deployment of balloon 46 in the ECA, in conjunction with the negative pressure in the venous sheath during diastole, will established a retrograde flow dynamic in the ICA, as shown in FIG. 5B .
- Continuous blood flow (except during inflation of any dilatation instruments) with reperfusion in accordance with the present invention provides efficient emboli removal with significantly reduced blood loss.
- filter 50 may be omitted, in which case emboli removed from the arterial side will be introduced into the venous side, and eventually captured in the lungs. Because of a low incidence of septal defects, which could permit such emboli to cross-over to the left ventricle, the use of filter 50 is preferred.
- an interventional instrument such as conventional angioplasty balloon catheter 71 having balloon 72 , is loaded through hemostatic port 43 and aspiration lumen 58 and positioned within the stenosis, preferably via guide wire 73 .
- Hemostatic port 43 is closed and instrument 71 is actuated to disrupt the plaque forming stenosis S.
- balloon 72 is deflated.
- the pressure differential between the blood in the ICA and the venous pressure causes blood in the ICA to flow in a retrograde direction into aspiration lumen 58 of emboli removal catheter 41 , thereby flushing any emboli from the vessel.
- the blood is filtered and reperfused into the patient's vein.
- the method of the present invention protects against embolization, first, by preventing the reversal of blood flow from the ECA to the ICA when distal occlusion element 42 is inflated, and second, by providing continuous, low volume blood flow from the carotid artery to the remote vein in order to filter and flush any emboli from the vessel and blood stream.
- the method of the present invention permits emboli to be removed with little blood loss, because the blood is filtered and reperfused into the patient. Furthermore, continuous removal of blood containing emboli prevents emboli from migrating too far downstream for aspiration.
- Apparatus 240 is an alternative embodiment of apparatus 40 described hereinabove and comprises arterial catheter 241 having proximal and distal ends, distal occlusion element 242 disposed on the distal end, proximal hemostatic port 243 , inflation port 244 and blood outlet port 248 .
- Self-expanding occlusion element 246 having proximal and distal ends preferably comprises non-expanding occlusion base 256 disposed at the proximal end, wherein occlusion base 256 comprises proximal taper 269 .
- Occlusion element 246 is coupled to retrieval wire 247 at the proximal end and atraumatic tip 245 at the distal end, e.g., by affixing retrieval wire 247 to proximal taper 269 of occlusion base 256 and affixing atraumatic tip 245 to a distal end of occlusion base 256 , as shown in FIG. 6A .
- Biocompatible tubing 249 couples blood outlet port 248 to filter 250 and to blood inlet port 251 of venous return sheath 252 .
- Arterial catheter 241 , venous return sheath 252 and tubing 249 are constructed as described hereinabove, except as noted below.
- Catheter 241 comprises aspiration lumen 258 , as shown in FIG. 6B , which is sized to permit interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through port 243 and the aspiration lumen.
- Retrieval wire lumen 264 is sized to permit longitudinal movement of retrieval wire 247 of occlusion element 246 .
- Retrieval wire lumen 264 spans from the proximal end of catheter 241 to a location just proximal of the distal end, e.g., about 1 to 2 cm proximal of the distal end of catheter 241 . At this location, retrieval wire lumen 264 merges with aspiration lumen 258 to form channel 265 , as shown in FIG. 6C .
- Occlusion element 246 initially is provided in a contracted state, as shown in FIG. 7A .
- occlusion element 246 is disposed within a lumen of dilator 270 , which in turn is disposed within aspiration lumen 258 of catheter 241 .
- Dilator 270 comprises proximal and distal ends, with occlusion element 246 being positioned within a slot in the distal end.
- the distal end of dilator 270 tapers and extends distal to catheter 241 , as shown in FIG. 7A .
- Atraumatic tip 245 of occlusion element 246 extends distal to dilator 270 and facilitates guidance of the device through a patient's vasculature.
- Push member 272 having proximal and distal ends is configured for longitudinal movement within the lumen of dilator 270 .
- the distal end of push member 272 preferably abuts occlusion base 256 of occlusion element 246 , while the proximal end of push member 272 may be manipulated by a physician.
- Dilator 270 comprises slot 271 disposed at the distal end. Slot 271 allows retrieval wire 247 to extend from a distal point in which it is coupled to occlusion base 256 , to a proximal point in which it enters retrieval wire lumen 264 , as shown in FIG. 7A .
- occlusion element 246 Upon positioning the distal end of catheter 241 at a selected location, push member 272 is held stationary while dilator 270 is retracted proximally, so that occlusion element 246 effectively is no longer constrained within the lumen of dilator 270 . This causes occlusion element 246 to self-expand to a predetermined shape, as shown in FIG. 7B . Occlusion element 246 is sized to occlude flow in the external carotid artery in this deployed state.
- Dilator slot 271 allows retrieval wire 247 to move freely during the deployment of occlusion element 246 .
- dilator 270 and push member 272 are removed from within aspiration lumen 258 , as shown in FIG. 7B .
- Catheter 241 then may be positioned separately from occlusion element 246 , as described hereinbelow with respect to FIG. 8 , and may be used to deliver other interventional apparatus, such as angioplasty catheters or stent delivery systems.
- occlusion element 246 is contracted by proximally retracting retrieval wire 247 .
- Occlusion element 246 is retrieved when the proximal load exerted on retrieval wire 247 exceeds the frictional forces between occlusion element 246 and the external carotid artery wall.
- occlusion base 256 , occlusion element 246 and atraumatic tip 245 may be retracted partially or fully into aspiration lumen 258 .
- 6C may be used to provide a transition at the distal end of catheter 241 so that occlusion element 246 is effectively guided into aspiration lumen 258 when retrieval wire 247 is retracted proximally. In effect, this allows occlusion element 246 to be contained within at least a distal portion of catheter 241 , to allow for safe removal of catheter 241 .
- stenosis S is located in the ICA above the carotid bifurcation.
- catheter 241 is inserted, either percutaneously and transluminally or via a surgical cut-down, to a position proximal of stenosis S.
- Occlusion element 246 is disposed within a lumen at the distal end of dilator 270 , as described in FIG. 7A , and atraumatic tip 245 is used to guide catheter 241 .
- the distal end of catheter 241 preferably is positioned within the ECA, as shown in FIG. 8A , so that occlusion element 246 will be deployed into the ECA.
- Push member 272 of FIG. 7A then is held stationary while dilator 270 is retracted proximally, so that occlusion element 246 is no longer constrained by dilator 270 .
- Occlusion element 246 then self-expands to occlude flow in the ECA, as shown in FIG. 8B .
- Dilator 270 and push member 272 then are removed from within aspiration lumen 258 , and catheter 241 is retracted to a location just proximal of the carotid bifurcation, as shown in FIG. 8B .
- Distal occlusion element 242 of catheter 241 then may be inflated via inflation port 244 to occlude antegrade flow in the CCA.
- Venous return sheath 252 may be introduced into the patient's femoral vein, either percutaneously or via a surgical cut-down, and filter 250 may be coupled between blood outlet port 248 of catheter 241 and blood inlet port 251 of venous return sheath 252 using tubing 249 . Once this circuit is closed, negative pressure in the venous sheath establishes a continuous retrograde flow of blood through aspiration lumen 258 of catheter 241 , as shown in FIG. 8B , to the patient's vein via venous return sheath 252 . Alternatively, venous return sheath 252 may be omitted, and the proximal end of catheter 241 connected to a receptacle to collect blood aspirated through aspiration lumen 258 .
- an interventional instrument such as conventional angioplasty balloon catheter 281 having balloon 282 , is loaded through hemostatic port 243 and aspiration lumen 258 and positioned within stenosis S, preferably via guide wire 283 .
- Hemostatic port 243 is closed and instrument 281 is actuated to disrupt stenosis S.
- balloon 282 is deflated.
- the pressure differential between the blood in the ICA and the venous pressure causes blood in the ICA to flow in a retrograde direction and into aspiration lumen 258 of emboli removal catheter 241 , thereby flushing any emboli E from the vessel.
- occlusion element 246 is contracted by proximally retracting retrieval wire 247 . Occlusion element 246 still further may be contracted when it contacts the distal end of catheter 241 .
- occlusion element 246 When occlusion element 246 has been contracted, it then may be retracted either partially or fully into aspiration lumen 258 of catheter 241 via channel 265 . Distal occlusion element 242 of catheter 241 then is deflated and the apparatus is removed from the patient's vessel.
Abstract
Methods and apparatus are provided for removing emboli during an angioplasty, stenting or surgical procedure comprising a catheter having an occlusion element, an aspiration lumen, and a blood outlet port in communication with the lumen, a guide wire having a balloon, a venous return sheath with a blood inlet port, and tubing that couples the blood outlet port to the blood inlet port. Apparatus is also provided for occluding the external carotid artery to prevent reversal of flow into the internal carotid artery. The pressure differential between the artery and the vein provides reverse flow through the artery, thereby flushing emboli. A blood filter may optionally be included in-line with the tubing to filter emboli from blood reperfused into the patient.
Description
- The present application is a divisional of pending U.S. patent application Ser. No. 11/156,865, filed Jun. 20, 2005, which is a divisional of pending U.S. patent application of Ser. No. 10/100,630, filed Mar. 15, 2002, now U.S. Pat. No. 6,908,474, issued Jun. 21, 2005, which is a continuation-in-part of U.S. patent application Ser. No. 09/418,727, filed Oct. 15, 1999, now U.S. Pat. No. 6,423,032, issued Jul. 23, 2002, which is a continuation-in-part of U.S. patent application Ser. No. 09/333,074, filed Jun. 14, 1999, now U.S. Pat. No. 6,206,868, which is a continuation-in-part of International Application PCT/US99/05469, filed Mar. 12, 1999, which is a continuation-in-part of U.S. patent application Ser. No. 09/078,263, filed May 13, 1998, now U.S. Pat. No. 6,413,235, Issued Jul. 2, 2002.
- This invention relates to apparatus and methods for protecting against embolization during vascular interventions, such as carotid artery angioplasty and endarterectomy. More particularly, the apparatus and methods of the present invention induce substantially continuous retrograde flow through the internal carotid artery during treatment during an interventional procedure, without significant blood loss.
- Carotid artery stenoses typically manifest in the common carotid artery, internal carotid artery or external carotid artery as a pathologic narrowing of the vascular wall, for example, caused by the deposition of plaque, that inhibits normal blood flow. Endarterectomy, an open surgical procedure, traditionally has been used to treat such stenosis of the carotid artery.
- An important problem encountered in carotid artery surgery is that emboli may be formed during the course of the procedure, and these emboli can rapidly pass into the cerebral vasculature and cause ischemic stroke.
- In view of the trauma and long recuperation times generally associated with open surgical procedures, considerable interest has arisen in the endovascular treatment of carotid artery stenosis. In particular, widespread interest has arisen in transforming interventional techniques developed for treating coronary artery disease, such as angioplasty and stenting, for use in the carotid arteries. Such endovascular treatments, however, are especially prone to the formation of emboli.
- Such emboli may be created, for example, when an interventional instrument, such as a guide wire or angioplasty balloon, is forcefully passed into or through the stenosis, as well as after dilatation and deflation of the angioplasty balloon or stent deployment. Because such instruments are advanced into the carotid artery in the same direction as blood flow, emboli generated by operation of the instruments are carried directly to the brain by antegrade blood flow. Stroke rates after carotid artery stenting have widely varied in different clinical series, from as low as 4.4% to as high as 30%. One review of carotid artery stenting including data from twenty-four major interventional centers in Europe, North America, South America and Asia, had a combined initial failure and combined mortality/stroke rate of more than 7%. Cognitive studies and reports of intellectual changes after carotid artery stenting indicate that embolization is a common event causing subclinical cerebral damage.
- Several previously known apparatus and methods attempt to remove emboli formed during endovascular procedures by trapping or suctioning the emboli out of the vessel of interest. These previously known systems, however, provide less than optimal solutions to the problems of effectively removing emboli.
- Solano et al. U.S. Pat. No. 4,921,478 describes cerebral angioplasty methods and devices wherein two concentric shafts are coupled at a distal end to a distally-facing funnel-shaped structure. A lumen of the innermost shaft communicates with an opening in the funnel-shaped structure at the distal end, and is open to atmospheric pressure at the proximal end. In use, the funnel-shaped structure is deployed proximally (in the direction of flow) of a stenosis, occluding antegrade flow. An angioplasty balloon catheter is passed through the innermost lumen and into the stenosis, and then inflated to dilate the stenosis. The patent states that when the angioplasty balloon is deflated, a pressure differential between atmospheric pressure and the blood distal to the angioplasty balloon causes a reversal of flow in the vessel that flushes any emboli created by the angioplasty balloon through the lumen of the innermost catheter.
- While a seemingly elegant solution to the problem of emboli removal, several drawbacks of the device and methods described in the Solano et al. patent seem to have lead to abandonment of that approach. Chief among these problems is the inability of that system to generate flow reversal during placement of the guide wire and the angioplasty balloon across the stenosis. Because flow reversal does not occur until after deflation of the angioplasty balloon, there is a substantial risk that any emboli created during placement of the angioplasty balloon will travel too far downstream to be captured by the subsequent flow reversal. It is expected that this problem is further compounded because only a relatively small volume of blood is removed by the pressure differential induced after deflation of the angioplasty balloon.
- Applicant has determined another drawback of the method described in the Solano patent: deployment of the funnel-shaped structure in the common carotid artery (“CCA”) causes reversal of flow from the external carotid artery (“ECA”) into the internal carotid artery (“ICA”). Consequently, when a guide wire or interventional instrument is passed across a lesion in either the ECA or ICA, emboli dislodged from the stenosis are introduced into the blood flow and carried into the cerebral vasculature via the ICA.
- The insufficient flow drawback identified for the system of the Solano patent is believed to have prevented development of a commercial embodiment of the similar system described in EP Publication No. 0 427 429. EP Publication No. 0 427 429 describes use of a separate balloon to occlude the ECA prior to crossing the lesion in the ICA. However, like Solano, that publication discloses that flow reversal occurs only when the dilatation balloon in the ICA is deflated.
-
Chapter 46 of Interventional Neuroradiology: strategies and practical techniques (J. J. Connors & J. Wojak, 1999), published by Saunders of Philadelphia, Pa., describes using a coaxial balloon angioplasty system for patients having proximal ICA stenoses. In particular, a small, deflated occlusion balloon on a wire is introduced into the origin of the ECA, and a guide catheter with a deflated occlusion balloon is positioned in the CCA just proximal to the origin of the ECA. A dilation catheter is advanced through a lumen of the guide catheter and dilated to disrupt the stenosis. Before deflation of the dilation catheter, the occlusion balloons on the guide catheter and in the ECA are inflated to block antegrade blood flow to the brain. The dilation balloon then is deflated, the dilation catheter is removed, and blood is aspirated from the ICA to remove emboli. - Applicant has determined that cerebral damage still may result from the foregoing previously known procedure, which is similar to that described in EP Publication No. 0 427 429, except that the ICA is occluded prior to the ECA. Consequently, both of these previously known systems and methods suffer from the same drawback—the inability to generate flow reversal at sufficiently high volumes during placement of the guide wire and dilation catheter across the stenosis. Both methods entail a substantial risk that any emboli created during placement of the balloon will travel too far downstream to be captured by the flow reversal.
- Applicants note, irrespective of the method of aspiration employed with the method described in the foregoing Interventional Neuroradioloqy article, substantial drawbacks are attendant. If, for example, natural aspiration is used (i.e., induced by the pressure gradient between the atmosphere and the artery), then only a relatively small volume of blood is expected to be removed by the pressure differential induced after deflation of the angioplasty balloon. If, on the other hand, an external pump is utilized, retrieval of these downstream emboli may require a flow rate that cannot be sustained for more than a few seconds, resulting insufficient removal of emboli.
- Furthermore, with the dilation balloon in position, the occlusion balloons are not inflated until after inflation of the dilation balloon. Microemboli generated during advancement of the dilation catheter into the stenosed segment may therefore be carried by antegrade blood flow into the brain before dilation, occlusion, and aspiration are even attempted.
- Imran U.S. Pat. No. 5,833,650 describes a system for treating stenoses that comprises three concentric shafts. The outermost shaft includes a proximal balloon at its distal end that is deployed proximal of a stenosis to occlude antegrade blood flow. A suction pump then draws suction through a lumen in the outermost shaft to cause a reversal of flow in the vessel while the innermost shaft is passed across the stenosis. Once located distal to the stenosis, a distal balloon on the innermost shaft is deployed to occlude flow distal to the stenosis. Autologous blood taken from a femoral artery using an extracorporeal blood pump is infused through a central lumen of the innermost catheter to provide continued antegrade blood flow distal to the distal balloon. The third concentric shaft, which includes an angioplasty balloon, is then advanced through the annulus between the innermost and outermost catheters to dilate the stenosis.
- Like the device of the Solano patent, the device of the Imran patent appears to suffer the drawback of potentially dislodging emboli that are carried into the cerebral vasculature. In particular, once the distal balloon of Imran's innermost shaft is deployed, flow reversal in the vasculature distal to the distal balloon ceases, and the blood perfused through the central lumen of the innermost shaft establishes antegrade flow. Importantly, if emboli are generated during deployment of the distal balloon, those emboli will be carried by the perfused blood directly into the cerebral vasculature, and again pose a risk of ischemic stroke. Moreover, there is some evidence that reperfusion of blood under pressure through a small diameter catheter may contribute to hemolysis and possible dislodgment of emboli.
- In applicant's co-pending U.S. patent application Ser. No. 09/333,074, filed Jun. 14, 1999, which is incorporated herein by reference, applicant described the use of external suction to induce regional reversal of flow. That application further described that intermittently induced regional flow reversal overcomes the drawbacks of naturally-aspirated systems such as described hereinabove. However, the use of external suction may in some instances result in flow rates that are too high to be sustained for more than a few seconds. In addition, continuous use of an external pump may result in excessive blood loss, requiring infusion of non-autologous blood and/or saline that causes hemodilution, reduced blood pressure, or raise related safety issues.
- In view of these drawbacks of the previously known emboli removal systems, it would be desirable to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that reduce the risk that emboli are carried into the cerebral vasculature.
- It also would be desirable to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that provide substantially continuous retrograde blood flow from the treatment zone, thereby reducing the risk that emboli are carried into the cerebral vasculature.
- It further would be desirable to provide emboli removal methods and apparatus that prevent the development of reverse flow from the ECA and antegrade into the ICA once the CCA has been occluded, thereby enhancing the likelihood that emboli generated by a surgical or interventional procedure are effectively removed from the vessel.
- It also would be desirable to provide methods and apparatus that allow for placement of an interventional device so that retrograde flow may be achieved in the treatment vessel prior to having a guide wire cross the lesion.
- It also would be desirable to provide methods and apparatus for removing emboli during an angioplasty or carotid stenting procedure that enable filtering of emboli and reduced blood loss.
- In view of the foregoing, it is an object of this invention to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that reduce the risk that emboli are carried into the cerebral vasculature.
- It also is an object of the present invention to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that provide substantially continuous retrograde blood flow from the treatment zone, thereby reducing the risk that emboli are carried into the cerebral vasculature.
- It is another object of the present invention to provide emboli removal methods and apparatus that prevent the development of reverse flow between the ECA and ICA once the common carotid artery has been occluded, thereby enhancing the likelihood that emboli generated by a surgical or interventional procedure are effectively removed from the vessel.
- It is still a further object of the present to provide methods and apparatus that allow for placement of an interventional device so that retrograde flow may be achieved in the treatment vessel prior to having a guide wire cross the lesion.
- It is yet another object of the present invention to provide methods and apparatus for removing emboli during an angioplasty or carotid stenting procedure that enable filtering of emboli and reduced blood loss.
- The foregoing objects of the present invention are accomplished by providing interventional apparatus comprising an arterial catheter, an occlusion element disposed on a guide wire, a venous return sheath, and optionally a blood filter. The arterial catheter has proximal and distal ends, an aspiration lumen extending therethrough, an occlusion element disposed on the distal end, and a hemostatic port and blood outlet port disposed on the proximal end that communicate with the aspiration lumen. The aspiration lumen is sized so that an interventional instrument, e.g., an angioplasty catheter or stent delivery system, may be readily advanced therethrough to the site of a stenosis in either the ECA (proximal to the occlusion element) or the ICA.
- In accordance with the principles of the present invention, the arterial catheter is disposed in the CCA proximal of the ICA/ECA bifurcation, the occlusion element on the guide wire is disposed in the ECA to occlude flow reversal from the ECA to the ICA, and the blood outlet port of the arterial catheter is coupled to the venous return sheath, with or without the blood filter disposed therebetween. Higher arterial than venous pressure, especially during diastole, permits substantially continuous flow reversal in the ICA during the procedure (other than when a dilatation balloon is inflated), thereby flushing blood containing emboli from the vessel. The blood is filtered and reperfused into the body through the venous return sheath.
- In an alternative embodiment, the occlusion element disposed on the guide wire may be omitted, and replaced with apparatus comprising a self-expanding element having proximal and distal ends, a retrieval wire coupled to the proximal end and an atraumatic tip coupled to the distal end. In this embodiment, a dilator having a lumen may be disposed within the aspiration lumen of the catheter so that the occlusion element is provided in a contracted state within the lumen of the dilator. The occlusion element then is ejected from the dilator and self-expands to occlude the ECA. The dilator then is removed from the aspiration lumen of the catheter, and the distal end of the catheter is re-positioned in the CCA proximal of the carotid bifurcation. Flow reversal is induced in the ICA, as described above, and the self-expanding occlusion element may be contracted using the retrieval wire provided.
- Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments, in which:
-
FIGS. 1A and 1B are schematic views of previously known emboli protection systems; -
FIG. 2 is a schematic view of an emboli protection system in accordance with principles of the present invention; -
FIGS. 3A-3D are, respectively, a schematic view of apparatus in accordance with a first embodiment of the present invention, detailed side and sectional views of the distal end of an interventional device of the present invention, and a cross-sectional view of an interventional device of the present invention; -
FIGS. 4A and 4B are views of the distal end of an alternative interventional device suitable for use in the system of the present invention; -
FIGS. 5A-5D illustrate a method of using the system ofFIG. 3 in accordance with the principles of the present invention; -
FIGS. 6A-6C are, respectively, a schematic view and cross-sectional views of the proximal and distal ends of a catheter of an alternative embodiment of the present invention; -
FIGS. 7A-7B depict features of the self-expanding occlusion element ofFIG. 6 ; and -
FIGS. 8A-8D illustrate a method of using the system ofFIG. 6 in accordance with the principles of the present invention. - Referring to
FIGS. 1A and 1B , drawbacks of previously known emboli removal catheters are described with reference to performing percutaneous angioplasty of stenosis S in common carotid artery CCA. - With respect to
FIG. 1A , drawbacks associated with naturally-aspirated emboli removal systems, such as described in the above-mentioned patent to Solano and European Patent Publication, are described. No flow reversal is induced by those systems until afterballoon 10 of angioplasty catheter 11 first is passed across the stenosis, inflated, and then deflated. However, applicant has determined that oncemember 15 ofemboli removal catheter 16 is inflated, flow within the ECA reverses and provides antegrade flow into the ICA, due to the lower hemodynamic resistance of the ICA. Consequently, emboli E generated while passingguide wire 20 or catheter 11 across stenosis S may be carried irretrievably into the cerebral vasculature, before flow in the vessel is reversed and directed into the aspiration lumen ofemboli removal catheter 16 by opening the proximal end of the aspiration lumen to atmospheric pressure. Furthermore, natural-aspiration may not remove an adequate volume of blood to retrieve even those emboli that have not yet been carried all the way into the cerebral vasculature. - In
FIG. 1B ,system 17 described in the above-mentioned patent to Imran is shown. As described hereinabove, deployment ofdistal balloon 18, and ejection of blood out of the distal end of the inner catheter, may dislodge emboli from the vessel wall distal toballoon 18. The introduction of antegrade flow throughinner catheter 19 is expected only to exacerbate the problem by pushing the emboli further into the cerebral vasculature. Thus, while the use of positive suction in the Imran system may remove emboli located in the confined treatment field defined by the proximal and distal balloons, such suction is not expected to provide any benefit for emboli dislodged distal ofdistal balloon 18. - Referring now to
FIG. 2 , apparatus and methods in accordance with the present invention are described.Apparatus 30 comprisescatheter 31 having an aspiration lumen andocclusion element 32, and guidewire 35 havinginflatable balloon 36 disposed on its distal end. In accordance with the principles of the present invention, antegrade blood flow is stopped when bothocclusion element 32 in the CCA andinflatable balloon 36 are deployed. Furthermore, the aspiration lumen ofcatheter 31 is connected to a venous return sheath (described hereinbelow), disposed, for example, in the patient's femoral vein. In this manner a substantially continuous flow of blood is induced between the treatment site and the patient's venous vasculature. Because flow through the artery is towardscatheter 31, any emboli dislodged by advancing a guide wire orangioplasty catheter 33 across stenosis S causes the emboli to be aspirated bycatheter 31. - Unlike the previously known naturally-aspirated systems, the present invention provides substantially continuous retrograde blood flow through the ICA while preventing blood from flowing retrograde in the ECA and antegrade into the ICA, thereby preventing emboli from being carried into the cerebral vasculature. Because the apparatus and methods of the present invention “recycle” emboli-laden blood from the arterial catheter through the blood filter and to the venous return sheath, the patient experiences significantly less blood loss.
- Referring now to
FIG. 3A ,embolic protection apparatus 40 constructed in accordance with the principles of the present invention is described.Apparatus 40 comprisesarterial catheter 41,guide wire 45,venous return sheath 52,tubing 49 andoptional blood filter 50. -
Catheter 41 includesdistal occlusion element 42, proximalhemostatic port 43, e.g., a Touhy-Borst connector,inflation port 44, andblood outlet port 48.Guide wire 45 includesballoon 46 that is inflated viainflation port 47.Tubing 49 couplesblood outlet port 48 to filter 50 andblood inlet port 51 ofvenous return sheath 52. -
Guide wire 45 andballoon 46 are configured to pass throughhemostatic port 43 and the aspiration lumen of catheter 41 (seeFIGS. 3C and 3D ), so that the balloon may be advanced into and occlude theECA. Port 43 and the aspiration lumen ofcatheter 41 are sized to permit additional interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through the aspiration lumen whenguide wire 45 is deployed. -
Guide wire 45 preferably comprises a small diameter flexible shaft having an inflation lumen that couplesinflatable balloon 46 toinflation port 47. -
Inflatable balloon 46 preferably comprises a compliant material, such as described hereinbelow with respect toocclusion element 42 ofemboli removal catheter 41. -
Venous return sheath 52 includeshemostatic port 53,blood inlet port 51 and a lumen that communicates withports tip 54. -
Venous return sheath 52 may be constructed in a manner per se known for venous introducer catheters.Tubing 49 may comprise a suitable length of a biocompatible material, such as silicone. Alternatively,tubing 49 may be omitted andblood outlet port 48 ofcatheter 41 andblood inlet port 51 ofvenous return sheath 52 may be lengthened to engage either end offilter 50 or each other. - With respect to
FIGS. 3B and 3C ,distal occlusion element 42 comprises expandable bell or pear-shapedballoon 55. In accordance with manufacturing techniques that are known in the art,balloon 55 comprises a compliant material, such as polyurethane, latex or polyisoprene which has variable thickness along its length to provide a bell-shape when inflated.Balloon 55 is affixed todistal end 56 ofcatheter 41, for example, by gluing or a melt-bond, so that opening 57 inballoon 55 leads intoaspiration lumen 58 ofcatheter 41.Balloon 55 preferably is wrapped and heat treated during manufacture so thatdistal portion 59 of the balloon extends beyond the distal end ofcatheter 41 and provides an atraumatic tip or bumper for the catheter. - As shown in
FIG. 3D ,catheter 41 preferably comprisesinner layer 60 of low-friction material, such as polytetrafluoroethylene (“PTFE”), covered with a layer of flat stainlesssteel wire braid 61 and polymer cover 62 (e.g., polyurethane, polyethylene, or PEBAX). Inflation lumen 63 is disposed withinpolymer cover 62 and couplesinflation port 44 toballoon 55. In a preferred embodiment ofcatheter 41, the diameter oflumen 58 is about 7 Fr, and the outer diameter of the catheter is about 9 Fr. - Referring now to
FIGS. 4A and 4B , an alternative embodiment ofocclusion element 42 of the system ofFIG. 3A is described. InFIGS. 4A and 4B ,occlusion element 42 ofemboli removal catheter 41 comprises self-expandingwire basket 65 covered withelastomeric polymer 66, such as latex, polyurethane or polyisoprene. Alternatively, a tightly knit self-expanding wire mesh may be used, with or without an elastomeric covering. -
Catheter 41 is contained withinmovable sheath 67.Catheter 41 is inserted transluminally withsheath 67 in a distalmost position, and afterbasket 65 has been determined to be in a desired position proximal to a stenosis,sheath 67 is retracted proximally to causebasket 65 to deploy. Upon completion of the procedure,basket 65 is again collapsed withinsheath 67 by moving the sheath to its distalmost position. Operation of the system ofFIG. 3A using the emboli removal catheter ofFIGS. 4A and 4B is similar to that described hereinbelow forFIGS. 5A-5D , except that the occlusion element self-expands whensheath 67 is retracted, rather than by infusing an inflation medium to balloon 55. - Referring now to
FIGS. 5A-5D , use of the apparatus ofFIG. 3 in accordance with the methods of the present invention is described. InFIG. 5 , stenosis S is located in internal carotid artery ICA above the bifurcation between the ICA and the external carotid artery ECA. In a first step,guide wire 80 is inserted into a patient's arterial vasculature and a distal end ofguide wire 80 preferably is disposed just proximal of the carotid bifurcation, as shown inFIG. 5A . A dilator (not shown), which is disposed withincatheter 41, then may be inserted overguide wire 80 to advancecatheter 41 to a position proximal of stenosis S, as shown inFIG. 5A , and the dilator may be removed.Balloon 55 ofdistal occlusion element 42 then is inflated viainflation port 44, preferably using a radiopaque contrast solution, and guidewire 80 may be removed. Onceballoon 55 ofdistal occlusion element 42 is inflated, flow within the ECA reverses and provides antegrade flow into the ICA, as shown inFIG. 5A , due to the lower hemodynamic resistance of the ICA. -
Venous return sheath 52 then is introduced into the patient's femoral vein, either percutaneously or via a surgical cut-down.Filter 50 then is coupled betweenblood outlet port 48 ofcatheter 41 andblood inlet port 51 ofvenous return sheath 52 usingtubing 49, and any air is removed from the line. Once this circuit is closed, negative pressure in the venous sheath during diastole will establish a low rate continuous flow of blood throughaspiration lumen 58 ofcatheter 41, to the patient's vein viavenous return sheath 52. -
Guide wire 45 andballoon 46 then may be advanced throughaspiration lumen 58. Whenballoon 46 is disposed within the ECA, as determined, e.g., using a fluoroscope and a radiopaque inflation medium injected intoballoon 46,balloon 46 is inflated. The deployment ofballoon 46 in the ECA, in conjunction with the negative pressure in the venous sheath during diastole, will established a retrograde flow dynamic in the ICA, as shown inFIG. 5B . - This continuous retrograde flow in the ICA due to the difference between venous pressure and arterial pressure will continue throughout the interventional procedure. Specifically, blood passes through
aspiration lumen 58 andblood outlet port 48 ofcatheter 41, throughbiocompatible tubing 49 to filter 50, and intoblood inlet port 51 ofvenous return sheath 52, where it is reperfused into the remote vein. Filtered emboli collect infilter 50 and may be studied and characterized upon completion of the procedure. - Continuous blood flow (except during inflation of any dilatation instruments) with reperfusion in accordance with the present invention provides efficient emboli removal with significantly reduced blood loss. Alternatively, filter 50 may be omitted, in which case emboli removed from the arterial side will be introduced into the venous side, and eventually captured in the lungs. Because of a low incidence of septal defects, which could permit such emboli to cross-over to the left ventricle, the use of
filter 50 is preferred. - Referring to
FIG. 5C , an interventional instrument, such as conventionalangioplasty balloon catheter 71 havingballoon 72, is loaded throughhemostatic port 43 andaspiration lumen 58 and positioned within the stenosis, preferably viaguide wire 73.Hemostatic port 43 is closed andinstrument 71 is actuated to disrupt the plaque forming stenosis S. - As seen in
FIG. 5D , upon completion of the angioplasty portion of theprocedure using catheter 71,balloon 72 is deflated. Throughout the procedure, except when the dilatation balloon is fully inflated, the pressure differential between the blood in the ICA and the venous pressure causes blood in the ICA to flow in a retrograde direction intoaspiration lumen 58 ofemboli removal catheter 41, thereby flushing any emboli from the vessel. The blood is filtered and reperfused into the patient's vein. - As set forth above, the method of the present invention protects against embolization, first, by preventing the reversal of blood flow from the ECA to the ICA when
distal occlusion element 42 is inflated, and second, by providing continuous, low volume blood flow from the carotid artery to the remote vein in order to filter and flush any emboli from the vessel and blood stream. Advantageously, the method of the present invention permits emboli to be removed with little blood loss, because the blood is filtered and reperfused into the patient. Furthermore, continuous removal of blood containing emboli prevents emboli from migrating too far downstream for aspiration. - Referring now to
FIG. 6 ,apparatus 240 constructed in accordance with the present invention is described.Apparatus 240 is an alternative embodiment ofapparatus 40 described hereinabove and comprisesarterial catheter 241 having proximal and distal ends,distal occlusion element 242 disposed on the distal end, proximalhemostatic port 243,inflation port 244 andblood outlet port 248. Self-expandingocclusion element 246 having proximal and distal ends preferably comprisesnon-expanding occlusion base 256 disposed at the proximal end, whereinocclusion base 256 comprisesproximal taper 269.Occlusion element 246 is coupled toretrieval wire 247 at the proximal end andatraumatic tip 245 at the distal end, e.g., by affixingretrieval wire 247 toproximal taper 269 ofocclusion base 256 and affixingatraumatic tip 245 to a distal end ofocclusion base 256, as shown inFIG. 6A .Biocompatible tubing 249 couplesblood outlet port 248 to filter 250 and toblood inlet port 251 ofvenous return sheath 252.Arterial catheter 241,venous return sheath 252 andtubing 249 are constructed as described hereinabove, except as noted below. -
Catheter 241 comprisesaspiration lumen 258, as shown inFIG. 6B , which is sized to permit interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced throughport 243 and the aspiration lumen.Retrieval wire lumen 264 is sized to permit longitudinal movement ofretrieval wire 247 ofocclusion element 246.Retrieval wire lumen 264 spans from the proximal end ofcatheter 241 to a location just proximal of the distal end, e.g., about 1 to 2 cm proximal of the distal end ofcatheter 241. At this location,retrieval wire lumen 264 merges withaspiration lumen 258 to formchannel 265, as shown inFIG. 6C . - Referring to
FIG. 7 , deployment ofocclusion element 246 is described.Occlusion element 246 initially is provided in a contracted state, as shown inFIG. 7A . In the contracted state,occlusion element 246 is disposed within a lumen ofdilator 270, which in turn is disposed withinaspiration lumen 258 ofcatheter 241.Dilator 270 comprises proximal and distal ends, withocclusion element 246 being positioned within a slot in the distal end. The distal end ofdilator 270 tapers and extends distal tocatheter 241, as shown inFIG. 7A .Atraumatic tip 245 ofocclusion element 246 extends distal todilator 270 and facilitates guidance of the device through a patient's vasculature. -
Push member 272 having proximal and distal ends is configured for longitudinal movement within the lumen ofdilator 270. During delivery ofcatheter 241, the distal end ofpush member 272 preferably abutsocclusion base 256 ofocclusion element 246, while the proximal end ofpush member 272 may be manipulated by a physician.Dilator 270 comprisesslot 271 disposed at the distal end.Slot 271 allowsretrieval wire 247 to extend from a distal point in which it is coupled toocclusion base 256, to a proximal point in which it entersretrieval wire lumen 264, as shown inFIG. 7A . - Upon positioning the distal end of
catheter 241 at a selected location,push member 272 is held stationary whiledilator 270 is retracted proximally, so thatocclusion element 246 effectively is no longer constrained within the lumen ofdilator 270. This causesocclusion element 246 to self-expand to a predetermined shape, as shown inFIG. 7B .Occlusion element 246 is sized to occlude flow in the external carotid artery in this deployed state. -
Dilator slot 271 allowsretrieval wire 247 to move freely during the deployment ofocclusion element 246. After deployment ofocclusion element 246,dilator 270 and pushmember 272 are removed from withinaspiration lumen 258, as shown inFIG. 7B .Catheter 241 then may be positioned separately fromocclusion element 246, as described hereinbelow with respect toFIG. 8 , and may be used to deliver other interventional apparatus, such as angioplasty catheters or stent delivery systems. - At the completion of the interventional procedure,
occlusion element 246 is contracted by proximally retractingretrieval wire 247.Occlusion element 246 is retrieved when the proximal load exerted onretrieval wire 247 exceeds the frictional forces betweenocclusion element 246 and the external carotid artery wall. Afterocclusion element 246 is contracted,occlusion base 256,occlusion element 246 andatraumatic tip 245 may be retracted partially or fully intoaspiration lumen 258.Channel 265 ofFIG. 6C may be used to provide a transition at the distal end ofcatheter 241 so thatocclusion element 246 is effectively guided intoaspiration lumen 258 whenretrieval wire 247 is retracted proximally. In effect, this allowsocclusion element 246 to be contained within at least a distal portion ofcatheter 241, to allow for safe removal ofcatheter 241. - Referring to
FIG. 8 , method steps for using the apparatus ofFIGS. 6-7 to treat carotid artery disease is provided. InFIG. 8 , stenosis S is located in the ICA above the carotid bifurcation. In a first step,catheter 241 is inserted, either percutaneously and transluminally or via a surgical cut-down, to a position proximal of stenosisS. Occlusion element 246 is disposed within a lumen at the distal end ofdilator 270, as described inFIG. 7A , andatraumatic tip 245 is used to guidecatheter 241. The distal end ofcatheter 241 preferably is positioned within the ECA, as shown inFIG. 8A , so thatocclusion element 246 will be deployed into the ECA. -
Push member 272 ofFIG. 7A then is held stationary whiledilator 270 is retracted proximally, so thatocclusion element 246 is no longer constrained bydilator 270.Occlusion element 246 then self-expands to occlude flow in the ECA, as shown inFIG. 8B .Dilator 270 and pushmember 272 then are removed from withinaspiration lumen 258, andcatheter 241 is retracted to a location just proximal of the carotid bifurcation, as shown inFIG. 8B .Distal occlusion element 242 ofcatheter 241 then may be inflated viainflation port 244 to occlude antegrade flow in the CCA. -
Venous return sheath 252 may be introduced into the patient's femoral vein, either percutaneously or via a surgical cut-down, and filter 250 may be coupled betweenblood outlet port 248 ofcatheter 241 andblood inlet port 251 ofvenous return sheath 252 usingtubing 249. Once this circuit is closed, negative pressure in the venous sheath establishes a continuous retrograde flow of blood throughaspiration lumen 258 ofcatheter 241, as shown inFIG. 8B , to the patient's vein viavenous return sheath 252. Alternatively,venous return sheath 252 may be omitted, and the proximal end ofcatheter 241 connected to a receptacle to collect blood aspirated throughaspiration lumen 258. - Referring to
FIG. 8C , withdistal occlusion element 242 inflated and a retrograde flow established in the ICA, an interventional instrument, such as conventionalangioplasty balloon catheter 281 havingballoon 282, is loaded throughhemostatic port 243 andaspiration lumen 258 and positioned within stenosis S, preferably viaguide wire 283.Hemostatic port 243 is closed andinstrument 281 is actuated to disrupt stenosis S. - As shown in
FIG. 8D , upon completion of the angioplasty portion of theprocedure using catheter 281,balloon 282 is deflated. Throughout the procedure, except when the dilatation balloon is fully inflated, the pressure differential between the blood in the ICA and the venous pressure causes blood in the ICA to flow in a retrograde direction and intoaspiration lumen 258 ofemboli removal catheter 241, thereby flushing any emboli E from the vessel. Upon satisfactory removal of emboli,occlusion element 246 is contracted by proximally retractingretrieval wire 247.Occlusion element 246 still further may be contracted when it contacts the distal end ofcatheter 241. Whenocclusion element 246 has been contracted, it then may be retracted either partially or fully intoaspiration lumen 258 ofcatheter 241 viachannel 265.Distal occlusion element 242 ofcatheter 241 then is deflated and the apparatus is removed from the patient's vessel. - While preferred illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made. The appended claims are intended to cover all such changes and modifications that fall within the true spirit and scope of the invention.
Claims (5)
1. A method of delivering an interventional instrument for treating a stenosis in an internal carotid artery comprising:
a) inserting an occlusion mechanism having a distal occlusion member and a balloon into a person's vasculature;
b) positioning the distal occlusion member to a desired position in the common carotid artery and the balloon to a desired position in the external carotid artery; and
c) operating the distal occlusion member and the balloon to occlude the external carotid artery and the central carotid artery.
2. A method according to claim 1 , wherein said occlusion mechanism further comprises a catheter having a proximal end and a distal end, an aspiration lumen extending therethrough, and said distal occlusion member positioned at said distal end of said catheter.
3. A method according to claim 2 , further comprising: aspirating blood through said aspiration lumen.
4. A method according to claim 2 , further comprising: inducing reverse flow to cause blood and emboli to flow into the aspiration lumen of the catheter.
5. A method according to claim 4 wherein inducing reverse flow further comprises:
a) providing a venous return sheath having a proximal end and a distal end, a lumen extending therethrough, and a blood inlet port coupled to the lumen; and
b) causing blood flow between the aspiration lumen of the catheter and the blood inlet port of the venous return sheath to induce reverse flow.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/043,402 US20110160762A1 (en) | 1998-05-13 | 2011-03-08 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/078,263 US6413235B1 (en) | 1998-03-13 | 1998-05-13 | Protective device against embolization in carotid angioplasty |
PCT/US1999/005469 WO1999045835A2 (en) | 1998-03-13 | 1999-03-12 | Protective device and method against embolization in carotid angioplasty |
US09/333,074 US6206868B1 (en) | 1998-03-13 | 1999-06-14 | Protective device and method against embolization during treatment of carotid artery disease |
US09/418,727 US6423032B2 (en) | 1998-03-13 | 1999-10-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US10/100,630 US6908474B2 (en) | 1998-05-13 | 2002-03-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US11/156,865 US7927347B2 (en) | 1998-05-13 | 2005-06-20 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US13/043,402 US20110160762A1 (en) | 1998-05-13 | 2011-03-08 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/156,865 Division US7927347B2 (en) | 1998-05-13 | 2005-06-20 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110160762A1 true US20110160762A1 (en) | 2011-06-30 |
Family
ID=28039859
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/100,630 Expired - Lifetime US6908474B2 (en) | 1998-05-13 | 2002-03-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US11/156,865 Expired - Fee Related US7927347B2 (en) | 1998-05-13 | 2005-06-20 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US12/763,923 Abandoned US20100204724A1 (en) | 1998-05-13 | 2010-04-20 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US13/043,402 Abandoned US20110160762A1 (en) | 1998-05-13 | 2011-03-08 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/100,630 Expired - Lifetime US6908474B2 (en) | 1998-05-13 | 2002-03-15 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US11/156,865 Expired - Fee Related US7927347B2 (en) | 1998-05-13 | 2005-06-20 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US12/763,923 Abandoned US20100204724A1 (en) | 1998-05-13 | 2010-04-20 | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
Country Status (3)
Country | Link |
---|---|
US (4) | US6908474B2 (en) |
AU (1) | AU2003224695A1 (en) |
WO (1) | WO2003077983A1 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104688290A (en) * | 2013-12-07 | 2015-06-10 | 复旦大学附属妇产科医院 | Method for internal compression hemostasis after minimally invasive breast lump rotary varicotomy and hemostatic balloon |
US9345499B2 (en) | 2011-05-26 | 2016-05-24 | Covidien Lp | Pressure activated foreign body removal system and method of use |
CN106102654A (en) * | 2014-01-10 | 2016-11-09 | 企斯动哈特有限公司 | Dissect independent deflector |
US9597171B2 (en) | 2012-09-11 | 2017-03-21 | Covidien Lp | Retrieval catheter with expandable tip |
US9987164B2 (en) | 2016-03-09 | 2018-06-05 | J.D. Franco & Co. | Systems and method for treating eye diseases using retrograde blood flow |
US10342699B2 (en) | 2012-08-03 | 2019-07-09 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases |
US10383644B2 (en) | 2013-10-17 | 2019-08-20 | Covidien Lp | Mechanical thrombectomy with proximal occlusion |
US10398880B2 (en) | 2017-11-02 | 2019-09-03 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
US10668258B1 (en) | 2018-12-31 | 2020-06-02 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
CN111248964A (en) * | 2020-01-16 | 2020-06-09 | 张跃国 | Cardiovascular internal medicine intervention device |
US10758409B2 (en) | 2014-12-29 | 2020-09-01 | J.D. Franco & Co., Llc | Apparatus and method for treating eye diseases |
US10758254B2 (en) | 2017-12-15 | 2020-09-01 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
US10772645B2 (en) | 2017-05-07 | 2020-09-15 | J.D. Franco & Co., Llc | Devices and methods for treating an artery |
US10779929B2 (en) | 2017-10-06 | 2020-09-22 | J.D. Franco & Co., Llc | Treating eye diseases by deploying a stent |
DE102020202401A1 (en) | 2020-02-25 | 2021-08-26 | Free Life Medical Gmbh | System for supplying and withdrawing blood and assembly process |
US11278389B2 (en) | 2016-12-08 | 2022-03-22 | J.D. Franco & Co., Llc | Methods and devices for treating an eye using a filter |
US11478249B2 (en) | 2018-02-23 | 2022-10-25 | J.D. Franco & Co., Llc | Ophthalmic artery therapy under reverse flow |
US11529130B2 (en) | 2017-01-25 | 2022-12-20 | J.D. Franco & Co., Llc | Blood vessel access and closure devices and related methods of use |
US11690985B2 (en) | 2016-09-24 | 2023-07-04 | J.D. Franco & Co., Llc | Systems and methods for single puncture percutaneous reverse blood flow |
Families Citing this family (163)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6350266B1 (en) * | 1995-02-02 | 2002-02-26 | Scimed Life Systems, Inc. | Hybrid stone retrieval device |
US6336934B1 (en) | 1997-11-07 | 2002-01-08 | Salviac Limited | Embolic protection device |
US7491216B2 (en) | 1997-11-07 | 2009-02-17 | Salviac Limited | Filter element with retractable guidewire tip |
US6161547A (en) * | 1999-01-15 | 2000-12-19 | Coaxia, Inc. | Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use |
US6918921B2 (en) | 1999-05-07 | 2005-07-19 | Salviac Limited | Support frame for an embolic protection device |
US6964672B2 (en) | 1999-05-07 | 2005-11-15 | Salviac Limited | Support frame for an embolic protection device |
WO2001045572A1 (en) | 1999-12-22 | 2001-06-28 | Boston Scientific Limited | Endoluminal occlusion-irrigation catheter and methods of use |
US6660021B1 (en) | 1999-12-23 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Intravascular device and system |
US6402771B1 (en) | 1999-12-23 | 2002-06-11 | Guidant Endovascular Solutions | Snare |
US6575997B1 (en) | 1999-12-23 | 2003-06-10 | Endovascular Technologies, Inc. | Embolic basket |
US6695813B1 (en) | 1999-12-30 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US7918820B2 (en) | 1999-12-30 | 2011-04-05 | Advanced Cardiovascular Systems, Inc. | Device for, and method of, blocking emboli in vessels such as blood arteries |
GB2369575A (en) | 2000-04-20 | 2002-06-05 | Salviac Ltd | An embolic protection system |
US6964670B1 (en) | 2000-07-13 | 2005-11-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection guide wire |
US9433457B2 (en) | 2000-12-09 | 2016-09-06 | Tsunami Medtech, Llc | Medical instruments and techniques for thermally-mediated therapies |
US6506203B1 (en) | 2000-12-19 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Low profile sheathless embolic protection system |
US7374560B2 (en) * | 2001-05-01 | 2008-05-20 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US7422579B2 (en) | 2001-05-01 | 2008-09-09 | St. Jude Medical Cardiology Divison, Inc. | Emboli protection devices and related methods of use |
US7338510B2 (en) | 2001-06-29 | 2008-03-04 | Advanced Cardiovascular Systems, Inc. | Variable thickness embolic filtering devices and method of manufacturing the same |
US6599307B1 (en) * | 2001-06-29 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Filter device for embolic protection systems |
US6638294B1 (en) | 2001-08-30 | 2003-10-28 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
US6592606B2 (en) | 2001-08-31 | 2003-07-15 | Advanced Cardiovascular Systems, Inc. | Hinged short cage for an embolic protection device |
US8262689B2 (en) | 2001-09-28 | 2012-09-11 | Advanced Cardiovascular Systems, Inc. | Embolic filtering devices |
US8444636B2 (en) | 2001-12-07 | 2013-05-21 | Tsunami Medtech, Llc | Medical instrument and method of use |
US7241304B2 (en) | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
EP1455681B1 (en) | 2001-12-21 | 2014-09-17 | Salviac Limited | A support frame for an embolic protection device |
US7549974B2 (en) | 2002-06-01 | 2009-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for medical interventions of body lumens |
US7252675B2 (en) | 2002-09-30 | 2007-08-07 | Advanced Cardiovascular, Inc. | Embolic filtering devices |
US7331973B2 (en) | 2002-09-30 | 2008-02-19 | Avdanced Cardiovascular Systems, Inc. | Guide wire with embolic filtering attachment |
US20040088000A1 (en) | 2002-10-31 | 2004-05-06 | Muller Paul F. | Single-wire expandable cages for embolic filtering devices |
US8591540B2 (en) | 2003-02-27 | 2013-11-26 | Abbott Cardiovascular Systems Inc. | Embolic filtering devices |
JP4691640B2 (en) * | 2003-10-03 | 2011-06-01 | メドトロニック,インコーポレイテッド | Inflatable sheath and device and method of manufacturing the same |
US8579892B2 (en) | 2003-10-07 | 2013-11-12 | Tsunami Medtech, Llc | Medical system and method of use |
US7892251B1 (en) | 2003-11-12 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Component for delivering and locking a medical device to a guide wire |
ES2390273T3 (en) | 2003-11-21 | 2012-11-08 | Silk Road Medical, Inc. | Apparatus for the treatment of a carotid artery |
JP4707678B2 (en) * | 2004-01-26 | 2011-06-22 | カソリック リミテッド | Catheter assembly with adjustable loop |
US7678129B1 (en) | 2004-03-19 | 2010-03-16 | Advanced Cardiovascular Systems, Inc. | Locking component for an embolic filter assembly |
US8795315B2 (en) | 2004-10-06 | 2014-08-05 | Cook Medical Technologies Llc | Emboli capturing device having a coil and method for capturing emboli |
US8137333B2 (en) * | 2005-10-25 | 2012-03-20 | Voyage Medical, Inc. | Delivery of biological compounds to ischemic and/or infarcted tissue |
US11478152B2 (en) | 2005-02-02 | 2022-10-25 | Intuitive Surgical Operations, Inc. | Electrophysiology mapping and visualization system |
US9510732B2 (en) | 2005-10-25 | 2016-12-06 | Intuitive Surgical Operations, Inc. | Methods and apparatus for efficient purging |
US7244243B2 (en) * | 2005-03-10 | 2007-07-17 | Banning Gray Lary | Catheter for treatment of severe pulmonary emboli |
US20060217660A1 (en) * | 2005-03-10 | 2006-09-28 | Lary Banning G | Catheter with semipermeable membrane for treatment of severe pulmonary emboli |
US8945169B2 (en) | 2005-03-15 | 2015-02-03 | Cook Medical Technologies Llc | Embolic protection device |
US8221446B2 (en) | 2005-03-15 | 2012-07-17 | Cook Medical Technologies | Embolic protection device |
US9259305B2 (en) | 2005-03-31 | 2016-02-16 | Abbott Cardiovascular Systems Inc. | Guide wire locking mechanism for rapid exchange and other catheter systems |
US20060259066A1 (en) * | 2005-04-28 | 2006-11-16 | Euteneuer Charles L | Bifurcated artery filter system |
US20060282115A1 (en) * | 2005-06-09 | 2006-12-14 | Abrams Robert M | Thin film vessel occlusion device |
US8109962B2 (en) | 2005-06-20 | 2012-02-07 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US7850708B2 (en) | 2005-06-20 | 2010-12-14 | Cook Incorporated | Embolic protection device having a reticulated body with staggered struts |
US8221348B2 (en) | 2005-07-07 | 2012-07-17 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection device and methods of use |
US7766934B2 (en) | 2005-07-12 | 2010-08-03 | Cook Incorporated | Embolic protection device with an integral basket and bag |
US7771452B2 (en) | 2005-07-12 | 2010-08-10 | Cook Incorporated | Embolic protection device with a filter bag that disengages from a basket |
US8002725B2 (en) * | 2005-07-18 | 2011-08-23 | Novostent Corporation | Embolic protection and plaque removal system with closed circuit aspiration and filtering |
US8187298B2 (en) | 2005-08-04 | 2012-05-29 | Cook Medical Technologies Llc | Embolic protection device having inflatable frame |
US8377092B2 (en) | 2005-09-16 | 2013-02-19 | Cook Medical Technologies Llc | Embolic protection device |
US8632562B2 (en) | 2005-10-03 | 2014-01-21 | Cook Medical Technologies Llc | Embolic protection device |
US8182508B2 (en) | 2005-10-04 | 2012-05-22 | Cook Medical Technologies Llc | Embolic protection device |
US8252017B2 (en) | 2005-10-18 | 2012-08-28 | Cook Medical Technologies Llc | Invertible filter for embolic protection |
US8216269B2 (en) | 2005-11-02 | 2012-07-10 | Cook Medical Technologies Llc | Embolic protection device having reduced profile |
US8152831B2 (en) | 2005-11-17 | 2012-04-10 | Cook Medical Technologies Llc | Foam embolic protection device |
US20070225750A1 (en) * | 2006-03-10 | 2007-09-27 | Brooke Ren | Embolic protection systems |
US20070239182A1 (en) * | 2006-04-03 | 2007-10-11 | Boston Scientific Scimed, Inc. | Thrombus removal device |
DE102006024176B4 (en) * | 2006-05-23 | 2008-08-28 | Pah, Gunnar M. | A device for filtering blood in the removal of heart valve stenosis and methods for eliminating heart valve stenosis |
US9055906B2 (en) | 2006-06-14 | 2015-06-16 | Intuitive Surgical Operations, Inc. | In-vivo visualization systems |
DE102006039236A1 (en) * | 2006-08-21 | 2008-02-28 | Variomed Ag | Apparatus and method for reducing or removing stenoses |
US20080097476A1 (en) * | 2006-09-01 | 2008-04-24 | Voyage Medical, Inc. | Precision control systems for tissue visualization and manipulation assemblies |
US20080071307A1 (en) | 2006-09-19 | 2008-03-20 | Cook Incorporated | Apparatus and methods for in situ embolic protection |
WO2008089264A1 (en) | 2007-01-16 | 2008-07-24 | Reviveflow, Inc. | Arterial-venous switching |
US9901434B2 (en) | 2007-02-27 | 2018-02-27 | Cook Medical Technologies Llc | Embolic protection device including a Z-stent waist band |
US9144509B2 (en) | 2007-05-31 | 2015-09-29 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US9149610B2 (en) | 2007-05-31 | 2015-10-06 | Abbott Cardiovascular Systems Inc. | Method and apparatus for improving delivery of an agent to a kidney |
US9364586B2 (en) | 2007-05-31 | 2016-06-14 | Abbott Cardiovascular Systems Inc. | Method and apparatus for improving delivery of an agent to a kidney |
US8216209B2 (en) | 2007-05-31 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US7867273B2 (en) | 2007-06-27 | 2011-01-11 | Abbott Laboratories | Endoprostheses for peripheral arteries and other body vessels |
US20100228269A1 (en) * | 2009-02-27 | 2010-09-09 | Garrison Michi E | Vessel closure clip device |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
ES2913223T3 (en) | 2007-07-18 | 2022-06-01 | Silk Road Medical Inc | Systems for establishing retrograde carotid arterial blood flow |
ATE505147T1 (en) | 2007-08-23 | 2011-04-15 | Aegea Medical Inc | UTERUS THERAPY DEVICE |
US8252018B2 (en) | 2007-09-14 | 2012-08-28 | Cook Medical Technologies Llc | Helical embolic protection device |
US9138307B2 (en) | 2007-09-14 | 2015-09-22 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US8419748B2 (en) | 2007-09-14 | 2013-04-16 | Cook Medical Technologies Llc | Helical thrombus removal device |
US20110213290A1 (en) * | 2007-12-20 | 2011-09-01 | Vortex Medical | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
EP3311875A1 (en) * | 2007-12-20 | 2018-04-25 | AngioDynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system |
US10517617B2 (en) | 2007-12-20 | 2019-12-31 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
US20170136158A1 (en) | 2015-10-16 | 2017-05-18 | Angiodynamics, Inc. | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
US20110213392A1 (en) * | 2007-12-20 | 2011-09-01 | Vortex Medical | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
US8613717B2 (en) | 2007-12-20 | 2013-12-24 | Angiodynamics, Inc. | Systems and methods for removing and fragmenting undesirable material within a circulatory system |
US11589880B2 (en) | 2007-12-20 | 2023-02-28 | Angiodynamics, Inc. | System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure |
US8506512B2 (en) * | 2007-12-20 | 2013-08-13 | Angio Dynamics | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
US8734374B2 (en) | 2007-12-20 | 2014-05-27 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system during a surgical procedure |
WO2009099764A1 (en) * | 2008-02-05 | 2009-08-13 | Silk Road Medical, Inc. | Interventional sheath with retention features |
ES2821762T3 (en) | 2008-02-05 | 2021-04-27 | Silk Road Medical Inc | Interventional catheter system |
US9924992B2 (en) | 2008-02-20 | 2018-03-27 | Tsunami Medtech, Llc | Medical system and method of use |
US8721632B2 (en) | 2008-09-09 | 2014-05-13 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US20100023034A1 (en) * | 2008-06-19 | 2010-01-28 | Coherex Medical, Inc. | Clot retrieval method and device |
US20110263976A1 (en) * | 2008-07-18 | 2011-10-27 | Hassan Ali H | Methods and Devices for Endovascular Introduction of an Agent |
EP2320810B1 (en) * | 2008-08-08 | 2019-10-23 | Incept, Llc | Apparatus for accessing and removing material from body lumens |
US8574245B2 (en) | 2008-08-13 | 2013-11-05 | Silk Road Medical, Inc. | Suture delivery device |
JP2012500049A (en) | 2008-08-13 | 2012-01-05 | シルク・ロード・メディカル・インコーポレイテッド | Suture delivery device |
WO2010075445A1 (en) | 2008-12-23 | 2010-07-01 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US8388644B2 (en) | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
EP2382001B1 (en) * | 2008-12-30 | 2019-03-06 | Cook Medical Technologies LLC | Balloon-tipped endoscopic system |
US20100204684A1 (en) * | 2009-01-13 | 2010-08-12 | Garrison Michi E | Methods and systems for performing neurointerventional procedures |
US11284931B2 (en) | 2009-02-03 | 2022-03-29 | Tsunami Medtech, Llc | Medical systems and methods for ablating and absorbing tissue |
WO2010141752A1 (en) | 2009-06-03 | 2010-12-09 | Silk Road Medical, Inc. | System and methods for controlling retrograde carotid arterial blood flow |
US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
US8500775B2 (en) * | 2009-12-02 | 2013-08-06 | Surefire Medical, Inc. | Protection device and method against embolization agent reflux |
US8696698B2 (en) * | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US9161801B2 (en) * | 2009-12-30 | 2015-10-20 | Tsunami Medtech, Llc | Medical system and method of use |
US9943353B2 (en) | 2013-03-15 | 2018-04-17 | Tsunami Medtech, Llc | Medical system and method of use |
WO2012064864A1 (en) | 2010-11-09 | 2012-05-18 | Aegea Medical Inc. | Positioning method and apparatus for delivering vapor to the uterus |
US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
JP2014521462A (en) | 2011-08-05 | 2014-08-28 | シルク・ロード・メディカル・インコーポレイテッド | Method and system for treating acute ischemic stroke |
US10779855B2 (en) | 2011-08-05 | 2020-09-22 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US20130204278A1 (en) * | 2011-08-12 | 2013-08-08 | Edward H. Cully | Systems for removal of atherosclerotic plaque or thrombus at a treatment site |
KR20140050675A (en) | 2011-08-12 | 2014-04-29 | 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 | Devices and methods for approximating the cross-sectional profile of vasculature having branches |
US9089668B2 (en) | 2011-09-28 | 2015-07-28 | Surefire Medical, Inc. | Flow directional infusion device |
CN104135960B (en) | 2011-10-07 | 2017-06-06 | 埃杰亚医疗公司 | A kind of uterine therapy device |
US9089341B2 (en) | 2012-02-28 | 2015-07-28 | Surefire Medical, Inc. | Renal nerve neuromodulation device |
US9084857B2 (en) | 2012-04-16 | 2015-07-21 | W. L. Gore & Associates, Inc. | Single access flow-reversal catheter devices and methods |
US11311365B2 (en) | 2012-07-06 | 2022-04-26 | Michael Zhadkevich | Catheter for prevention of stroke and method of use |
US9498225B2 (en) | 2012-07-06 | 2016-11-22 | Michael Zhadkevich | Occluding catheter and method for prevention of stroke |
US9913967B2 (en) | 2012-07-06 | 2018-03-13 | Michael Zhadkevich | Occluding catheter and dynamic method for prevention of stroke |
US10537308B2 (en) | 2012-07-06 | 2020-01-21 | Michael Zhadkevich | Catheter for prevention of stroke and method of use |
US11013515B2 (en) | 2012-07-06 | 2021-05-25 | Michael Zhadkevich | Occluding catheter with an optional common inflation and guideware channel and method of use |
US9597084B2 (en) * | 2012-07-17 | 2017-03-21 | Michael Zhadkevich | Carotid artery occluding apparatus with first and second occluding balloons |
US11160957B2 (en) | 2012-07-17 | 2021-11-02 | Michael Zhadkevich | Carotid artery occluding apparatus with first, second and third occluding balloons |
WO2014025930A1 (en) | 2012-08-09 | 2014-02-13 | Silk Road Medical, Inc. | Suture delivery device |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US9855066B2 (en) * | 2013-03-12 | 2018-01-02 | Boston Scientific Scimed, Inc. | Retrieval device and related methods of use |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US9241699B1 (en) | 2014-09-04 | 2016-01-26 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US9889031B1 (en) | 2014-03-25 | 2018-02-13 | Surefire Medical, Inc. | Method of gastric artery embolization |
US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US20150297250A1 (en) | 2014-04-16 | 2015-10-22 | Covidien Lp | Systems and methods for catheter advancement |
US10182801B2 (en) | 2014-05-16 | 2019-01-22 | Silk Road Medical, Inc. | Vessel access and closure assist system and method |
EP3145426B1 (en) | 2014-05-22 | 2023-03-22 | Aegea Medical, Inc. | Apparatus for delivering vapor to the uterus |
WO2015179666A1 (en) | 2014-05-22 | 2015-11-26 | Aegea Medical Inc. | Systems and methods for performing endometrial ablation |
US11027104B2 (en) | 2014-09-04 | 2021-06-08 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US20160175569A1 (en) * | 2014-12-22 | 2016-06-23 | Richard R. Heuser | Device for treating vascular occlusion |
US11065019B1 (en) | 2015-02-04 | 2021-07-20 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
DE202016009165U1 (en) | 2015-02-04 | 2023-04-26 | Route 92 Medical, Inc. | Rapid Aspiration Thrombectomy System |
US20160287839A1 (en) | 2015-03-31 | 2016-10-06 | Surefire Medical, Inc. | Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment |
EP3280354B1 (en) | 2015-04-10 | 2019-09-04 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
JP6368291B2 (en) * | 2015-10-20 | 2018-08-01 | 朝日インテック株式会社 | catheter |
WO2017143343A1 (en) | 2016-02-19 | 2017-08-24 | Aegea Medical Inc. | Methods and apparatus for determining the integrity of a bodily cavity |
JP6937775B2 (en) * | 2016-03-18 | 2021-09-22 | プロセプト バイオロボティクス コーポレイション | Minimally invasive methods and systems for hemostasis in bleeding closed tissue volume |
US11524095B2 (en) * | 2016-06-30 | 2022-12-13 | St. Jude Medical, Cardiology Division, Inc. | Medical delivery devices and methods of making and using same |
US11400263B1 (en) | 2016-09-19 | 2022-08-02 | Trisalus Life Sciences, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US10780250B1 (en) | 2016-09-19 | 2020-09-22 | Surefire Medical, Inc. | System and method for selective pressure-controlled therapeutic delivery |
USD916281S1 (en) | 2016-10-17 | 2021-04-13 | Angiodynamics, Inc. | Reinforcement arms and collar for a cannula tip |
DE202017106887U1 (en) | 2016-11-14 | 2017-12-05 | Cathaway Medical (2012) Ltd. | Catheter with asymmetrical cross section |
US10588636B2 (en) | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
WO2019089385A1 (en) | 2017-11-02 | 2019-05-09 | Silk Road Medical, Inc. | Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization |
US11123078B2 (en) * | 2017-11-30 | 2021-09-21 | Boston Scientific Scimed, Inc. | Delivery and occlusion devices for paravalvular leak |
CN115999019A (en) | 2018-05-17 | 2023-04-25 | 92号医疗公司 | Aspiration catheter system and method of use |
US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
US11338117B2 (en) | 2018-10-08 | 2022-05-24 | Trisalus Life Sciences, Inc. | Implantable dual pathway therapeutic agent delivery port |
US11077288B2 (en) | 2018-11-15 | 2021-08-03 | Biosense Webster (Israel) Ltd. | Flushing balloon catheter for observation and removal of clots under vessel bifurcation conditions |
US11648020B2 (en) | 2020-02-07 | 2023-05-16 | Angiodynamics, Inc. | Device and method for manual aspiration and removal of an undesirable material |
CN117202872A (en) | 2021-01-17 | 2023-12-08 | 印斯拜尔Md有限公司 | Shunt with blood flow indicator |
USD972723S1 (en) | 2021-03-17 | 2022-12-13 | Angiodynamics, Inc. | Reinforcement arms and collar for an expandable cannula tip |
Citations (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2687131A (en) * | 1952-09-17 | 1954-08-24 | Davol Rubber Co | Female incontinence catheter |
US3634924A (en) * | 1970-04-20 | 1972-01-18 | American Hospital Supply Corp | Method of making multilumen balloon catheter |
US3831587A (en) * | 1973-02-08 | 1974-08-27 | Mc Anally R | Multipurpose vaginal and cervical device |
US3889685A (en) * | 1973-11-02 | 1975-06-17 | Cutter Lab | Tubular unit with vessel engaging cuff structure |
US4014206A (en) * | 1975-03-31 | 1977-03-29 | Akron City Hospital | Apparatus and method for monitoring air emboli during extracorporeal circulation |
US4451256A (en) * | 1981-05-06 | 1984-05-29 | Intermedicat Gmbh | Catheter set |
US4571240A (en) * | 1983-08-12 | 1986-02-18 | Advanced Cardiovascular Systems, Inc. | Catheter having encapsulated tip marker |
US4575371A (en) * | 1981-04-16 | 1986-03-11 | Percy Nordqvist | Urinary catheter |
US4577631A (en) * | 1984-11-16 | 1986-03-25 | Kreamer Jeffry W | Aneurysm repair apparatus and method |
US4781681A (en) * | 1987-09-15 | 1988-11-01 | Gv Medical, Inc. | Inflatable tip for laser catheterization |
US4794928A (en) * | 1987-06-10 | 1989-01-03 | Kletschka Harold D | Angioplasty device and method of using the same |
US4820270A (en) * | 1982-10-08 | 1989-04-11 | David Hardcastle | Balloon catheter and process for the manufacture thereof |
US4917667A (en) * | 1988-02-11 | 1990-04-17 | Retroperfusion Systems, Inc. | Retroperfusion balloon catheter and method |
US4921478A (en) * | 1988-02-23 | 1990-05-01 | C. R. Bard, Inc. | Cerebral balloon angioplasty system |
US5011488A (en) * | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US5030227A (en) * | 1988-06-02 | 1991-07-09 | Advanced Surgical Intervention, Inc. | Balloon dilation catheter |
US5071407A (en) * | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
US5074845A (en) * | 1989-07-18 | 1991-12-24 | Baxter International Inc. | Catheter with heat-fused balloon with waist |
US5102415A (en) * | 1989-09-06 | 1992-04-07 | Guenther Rolf W | Apparatus for removing blood clots from arteries and veins |
US5141494A (en) * | 1990-02-15 | 1992-08-25 | Danforth Biomedical, Inc. | Variable wire diameter angioplasty dilatation balloon catheter |
US5171305A (en) * | 1991-10-17 | 1992-12-15 | Imagyn Medical, Inc. | Linear eversion catheter with reinforced inner body extension |
US5195980A (en) * | 1992-01-03 | 1993-03-23 | Thomas Medical Products, Inc. | Hemostatic valve |
US5221261A (en) * | 1990-04-12 | 1993-06-22 | Schneider (Usa) Inc. | Radially expandable fixation member |
US5358472A (en) * | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Guidewire atherectomy catheter and method of using the same |
US5370618A (en) * | 1992-11-20 | 1994-12-06 | World Medical Manufacturing Corporation | Pulmonary artery polyurethane balloon catheter |
US5439446A (en) * | 1994-06-30 | 1995-08-08 | Boston Scientific Corporation | Stent and therapeutic delivery system |
US5441485A (en) * | 1994-02-24 | 1995-08-15 | Peters; Michael J. | Bladder catheter |
US5465259A (en) * | 1992-08-14 | 1995-11-07 | Fujitsu Limited | LSI system with a plurality of LSIs having different scan systems and provided on a printed circuit board |
US5478309A (en) * | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US5484412A (en) * | 1994-04-19 | 1996-01-16 | Pierpont; Brien E. | Angioplasty method and means for performing angioplasty |
US5499975A (en) * | 1989-01-31 | 1996-03-19 | Cook Incorporated | Smooth transitioned dilator-sheath assembly and method |
US5522882A (en) * | 1994-10-21 | 1996-06-04 | Impra, Inc. | Method and apparatus for balloon expandable stent-graft delivery |
US5527292A (en) * | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
US5549626A (en) * | 1994-12-23 | 1996-08-27 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Vena caval filter |
US5558644A (en) * | 1991-07-16 | 1996-09-24 | Heartport, Inc. | Retrograde delivery catheter and method for inducing cardioplegic arrest |
US5569204A (en) * | 1993-06-24 | 1996-10-29 | Schneider (Europe) A.G. | Aspiration catheter arrangement |
US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5601591A (en) * | 1994-09-23 | 1997-02-11 | Vidamed, Inc. | Stent for use in prostatic urethra, apparatus and placement device for same and method |
US5601581A (en) * | 1995-05-19 | 1997-02-11 | General Surgical Innovations, Inc. | Methods and devices for blood vessel harvesting |
US5639274A (en) * | 1995-06-02 | 1997-06-17 | Fischell; Robert E. | Integrated catheter system for balloon angioplasty and stent delivery |
US5653689A (en) * | 1995-09-30 | 1997-08-05 | Abacus Design & Development, Inc. | Infusion catheter |
US5669927A (en) * | 1994-11-10 | 1997-09-23 | Richard Wolf Gmbh | Instrument for morcellating |
US5669924A (en) * | 1995-10-26 | 1997-09-23 | Shaknovich; Alexander | Y-shuttle stent assembly for bifurcating vessels and method of using the same |
US5702373A (en) * | 1995-08-31 | 1997-12-30 | Target Therapeutics, Inc. | Composite super-elastic alloy braid reinforced catheter |
US5766151A (en) * | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5766203A (en) * | 1995-07-20 | 1998-06-16 | Intelliwire, Inc. | Sheath with expandable distal extremity and balloon catheters and stents for use therewith and method |
US5794629A (en) * | 1996-11-27 | 1998-08-18 | The Regents Of The University Of California | Method for treating ischemic brain stroke |
US5807326A (en) * | 1992-04-27 | 1998-09-15 | Minnesota Mining And Manufacturing Company | Retrograde coronary sinus catheter |
US5833650A (en) * | 1995-06-05 | 1998-11-10 | Percusurge, Inc. | Catheter apparatus and method for treating occluded vessels |
US5843027A (en) * | 1996-12-04 | 1998-12-01 | Cardiovascular Dynamics, Inc. | Balloon sheath |
US5895399A (en) * | 1996-07-17 | 1999-04-20 | Embol-X Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US5910154A (en) * | 1997-05-08 | 1999-06-08 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment |
US5916193A (en) * | 1991-07-16 | 1999-06-29 | Heartport, Inc. | Endovascular cardiac venting catheter and method |
US5919163A (en) * | 1997-07-14 | 1999-07-06 | Delcath Systems, Inc. | Catheter with slidable balloon |
US5925016A (en) * | 1995-09-27 | 1999-07-20 | Xrt Corp. | Systems and methods for drug delivery including treating thrombosis by driving a drug or lytic agent through the thrombus by pressure |
US5941896A (en) * | 1997-09-08 | 1999-08-24 | Montefiore Hospital And Medical Center | Filter and method for trapping emboli during endovascular procedures |
US5997503A (en) * | 1998-02-12 | 1999-12-07 | Ballard Medical Products | Catheter with distally distending balloon |
US6013085A (en) * | 1997-11-07 | 2000-01-11 | Howard; John | Method for treating stenosis of the carotid artery |
US6022336A (en) * | 1996-05-20 | 2000-02-08 | Percusurge, Inc. | Catheter system for emboli containment |
US6027476A (en) * | 1992-12-03 | 2000-02-22 | Heartport, Inc. | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
US6029671A (en) * | 1991-07-16 | 2000-02-29 | Heartport, Inc. | System and methods for performing endovascular procedures |
US6042559A (en) * | 1998-02-24 | 2000-03-28 | Innercool Therapies, Inc. | Insulated catheter for selective organ perfusion |
US6056720A (en) * | 1998-11-24 | 2000-05-02 | Embol-X, Inc. | Occlusion cannula and methods of use |
US6059745A (en) * | 1997-05-20 | 2000-05-09 | Gelbfish; Gary A. | Thrombectomy device and associated method |
US6066158A (en) * | 1996-07-25 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot encasing and removal wire |
US6090096A (en) * | 1997-04-23 | 2000-07-18 | Heartport, Inc. | Antegrade cardioplegia catheter and method |
US6099497A (en) * | 1998-03-05 | 2000-08-08 | Scimed Life Systems, Inc. | Dilatation and stent delivery system for bifurcation lesions |
US6120477A (en) * | 1995-09-18 | 2000-09-19 | Gore Enterprise Holdings, Inc. | Balloon catheter device |
US6126635A (en) * | 1993-09-29 | 2000-10-03 | Advanced Cardiovascular Systems, Inc. | Adjustable treatment chamber catheter |
US6129708A (en) * | 1989-01-30 | 2000-10-10 | Medtronic Ave, Inc. | Rapidly exchangeable coronary catheter |
US6135991A (en) * | 1997-03-06 | 2000-10-24 | Percusurge, Inc. | Aspiration method |
US6161547A (en) * | 1999-01-15 | 2000-12-19 | Coaxia, Inc. | Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use |
US6165199A (en) * | 1999-01-12 | 2000-12-26 | Coaxia, Inc. | Medical device for removing thromboembolic material from cerebral arteries and methods of use |
US6176851B1 (en) * | 1996-05-14 | 2001-01-23 | Embol-X, Inc. | Cardioplegia occluder |
US6180059B1 (en) * | 1995-06-05 | 2001-01-30 | Therox, Inc. | Method for the preparation and delivery of gas-enriched fluids |
US6206868B1 (en) * | 1998-03-13 | 2001-03-27 | Arteria Medical Science, Inc. | Protective device and method against embolization during treatment of carotid artery disease |
US6221042B1 (en) * | 1999-09-17 | 2001-04-24 | Scimed Life Systems, Inc. | Balloon with reversed cones |
US6228052B1 (en) * | 1996-02-29 | 2001-05-08 | Medtronic Inc. | Dilator for introducer system having injection port |
US6238412B1 (en) * | 1997-11-12 | 2001-05-29 | William Dubrul | Biological passageway occlusion removal |
US6295989B1 (en) * | 1997-02-06 | 2001-10-02 | Arteria Medical Science, Inc. | ICA angioplasty with cerebral protection |
US6379373B1 (en) * | 1998-08-14 | 2002-04-30 | Confluent Surgical, Inc. | Methods and apparatus for intraluminal deposition of hydrogels |
US6413235B1 (en) * | 1998-03-13 | 2002-07-02 | Arteria Medical Science, Inc. | Protective device against embolization in carotid angioplasty |
US20020087119A1 (en) * | 1998-03-13 | 2002-07-04 | Arteria Medical Science, Inc. | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US6458139B1 (en) * | 1999-06-21 | 2002-10-01 | Endovascular Technologies, Inc. | Filter/emboli extractor for use in variable sized blood vessels |
US6540712B1 (en) * | 1998-03-13 | 2003-04-01 | Arteria Medical Science, Inc. | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041089A (en) * | 1987-12-11 | 1991-08-20 | Devices For Vascular Intervention, Inc. | Vascular dilation catheter construction |
AU6376190A (en) | 1989-10-25 | 1991-05-02 | C.R. Bard Inc. | Occluding catheter and methods for treating cerebral arteries |
US5049128A (en) * | 1990-02-06 | 1991-09-17 | Duquette Irene A | Valved infusion port |
US5281200A (en) * | 1992-12-08 | 1994-01-25 | Cordis Corporation | Multiple component balloon catheter system and stenosis treatment procedure |
US6544276B1 (en) * | 1996-05-20 | 2003-04-08 | Medtronic Ave. Inc. | Exchange method for emboli containment |
US5906605A (en) * | 1997-01-10 | 1999-05-25 | Cardiac Pathways Corporation | Torquable guiding catheter for basket deployment and method |
US6231588B1 (en) * | 1998-08-04 | 2001-05-15 | Percusurge, Inc. | Low profile catheter for angioplasty and occlusion |
US6285989B1 (en) * | 1998-08-07 | 2001-09-04 | Ariba, Inc. | Universal on-line trading market design and deployment system |
-
2002
- 2002-03-15 US US10/100,630 patent/US6908474B2/en not_active Expired - Lifetime
-
2003
- 2003-03-13 WO PCT/US2003/007987 patent/WO2003077983A1/en not_active Application Discontinuation
- 2003-03-13 AU AU2003224695A patent/AU2003224695A1/en not_active Abandoned
-
2005
- 2005-06-20 US US11/156,865 patent/US7927347B2/en not_active Expired - Fee Related
-
2010
- 2010-04-20 US US12/763,923 patent/US20100204724A1/en not_active Abandoned
-
2011
- 2011-03-08 US US13/043,402 patent/US20110160762A1/en not_active Abandoned
Patent Citations (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2687131A (en) * | 1952-09-17 | 1954-08-24 | Davol Rubber Co | Female incontinence catheter |
US3634924A (en) * | 1970-04-20 | 1972-01-18 | American Hospital Supply Corp | Method of making multilumen balloon catheter |
US3831587A (en) * | 1973-02-08 | 1974-08-27 | Mc Anally R | Multipurpose vaginal and cervical device |
US3889685A (en) * | 1973-11-02 | 1975-06-17 | Cutter Lab | Tubular unit with vessel engaging cuff structure |
US4014206A (en) * | 1975-03-31 | 1977-03-29 | Akron City Hospital | Apparatus and method for monitoring air emboli during extracorporeal circulation |
US4575371A (en) * | 1981-04-16 | 1986-03-11 | Percy Nordqvist | Urinary catheter |
US4451256A (en) * | 1981-05-06 | 1984-05-29 | Intermedicat Gmbh | Catheter set |
US4820270A (en) * | 1982-10-08 | 1989-04-11 | David Hardcastle | Balloon catheter and process for the manufacture thereof |
US4571240A (en) * | 1983-08-12 | 1986-02-18 | Advanced Cardiovascular Systems, Inc. | Catheter having encapsulated tip marker |
US4577631A (en) * | 1984-11-16 | 1986-03-25 | Kreamer Jeffry W | Aneurysm repair apparatus and method |
US4794928A (en) * | 1987-06-10 | 1989-01-03 | Kletschka Harold D | Angioplasty device and method of using the same |
US4781681A (en) * | 1987-09-15 | 1988-11-01 | Gv Medical, Inc. | Inflatable tip for laser catheterization |
US4917667A (en) * | 1988-02-11 | 1990-04-17 | Retroperfusion Systems, Inc. | Retroperfusion balloon catheter and method |
US4921478A (en) * | 1988-02-23 | 1990-05-01 | C. R. Bard, Inc. | Cerebral balloon angioplasty system |
US5030227A (en) * | 1988-06-02 | 1991-07-09 | Advanced Surgical Intervention, Inc. | Balloon dilation catheter |
US5011488A (en) * | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US6129708A (en) * | 1989-01-30 | 2000-10-10 | Medtronic Ave, Inc. | Rapidly exchangeable coronary catheter |
US5499975A (en) * | 1989-01-31 | 1996-03-19 | Cook Incorporated | Smooth transitioned dilator-sheath assembly and method |
US5074845A (en) * | 1989-07-18 | 1991-12-24 | Baxter International Inc. | Catheter with heat-fused balloon with waist |
US5102415A (en) * | 1989-09-06 | 1992-04-07 | Guenther Rolf W | Apparatus for removing blood clots from arteries and veins |
US5141494A (en) * | 1990-02-15 | 1992-08-25 | Danforth Biomedical, Inc. | Variable wire diameter angioplasty dilatation balloon catheter |
US5071407A (en) * | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
US5221261A (en) * | 1990-04-12 | 1993-06-22 | Schneider (Usa) Inc. | Radially expandable fixation member |
US5527292A (en) * | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5916193A (en) * | 1991-07-16 | 1999-06-29 | Heartport, Inc. | Endovascular cardiac venting catheter and method |
US5766151A (en) * | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5738652A (en) * | 1991-07-16 | 1998-04-14 | Heartport, Inc. | Retrograde delivery catheter and method for inducing cardioplegic arrest |
US6029671A (en) * | 1991-07-16 | 2000-02-29 | Heartport, Inc. | System and methods for performing endovascular procedures |
US5558644A (en) * | 1991-07-16 | 1996-09-24 | Heartport, Inc. | Retrograde delivery catheter and method for inducing cardioplegic arrest |
US5814016A (en) * | 1991-07-16 | 1998-09-29 | Heartport, Inc. | Endovascular system for arresting the heart |
US5171305A (en) * | 1991-10-17 | 1992-12-15 | Imagyn Medical, Inc. | Linear eversion catheter with reinforced inner body extension |
US5195980A (en) * | 1992-01-03 | 1993-03-23 | Thomas Medical Products, Inc. | Hemostatic valve |
US5358472A (en) * | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Guidewire atherectomy catheter and method of using the same |
US5807326A (en) * | 1992-04-27 | 1998-09-15 | Minnesota Mining And Manufacturing Company | Retrograde coronary sinus catheter |
US5465259A (en) * | 1992-08-14 | 1995-11-07 | Fujitsu Limited | LSI system with a plurality of LSIs having different scan systems and provided on a printed circuit board |
US5370618A (en) * | 1992-11-20 | 1994-12-06 | World Medical Manufacturing Corporation | Pulmonary artery polyurethane balloon catheter |
US6027476A (en) * | 1992-12-03 | 2000-02-22 | Heartport, Inc. | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
US5569204A (en) * | 1993-06-24 | 1996-10-29 | Schneider (Europe) A.G. | Aspiration catheter arrangement |
US6126635A (en) * | 1993-09-29 | 2000-10-03 | Advanced Cardiovascular Systems, Inc. | Adjustable treatment chamber catheter |
US5441485A (en) * | 1994-02-24 | 1995-08-15 | Peters; Michael J. | Bladder catheter |
US5484412A (en) * | 1994-04-19 | 1996-01-16 | Pierpont; Brien E. | Angioplasty method and means for performing angioplasty |
US5765568A (en) * | 1994-05-27 | 1998-06-16 | Heartport, Inc. | Catheter system and method for venting the left ventricle |
US5800375A (en) * | 1994-05-27 | 1998-09-01 | Heartport, Inc. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US6398752B1 (en) * | 1994-05-27 | 2002-06-04 | William P. Sweezer, Jr. | Method of occluding a patient's ascending aorta and delivery cardioplegic fluid |
US5478309A (en) * | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US5810757A (en) * | 1994-05-27 | 1998-09-22 | Heartport, Inc. | Catheter system and method for total isolation of the heart |
US5439446A (en) * | 1994-06-30 | 1995-08-08 | Boston Scientific Corporation | Stent and therapeutic delivery system |
US5601591A (en) * | 1994-09-23 | 1997-02-11 | Vidamed, Inc. | Stent for use in prostatic urethra, apparatus and placement device for same and method |
US5522882A (en) * | 1994-10-21 | 1996-06-04 | Impra, Inc. | Method and apparatus for balloon expandable stent-graft delivery |
US5669927A (en) * | 1994-11-10 | 1997-09-23 | Richard Wolf Gmbh | Instrument for morcellating |
US5549626A (en) * | 1994-12-23 | 1996-08-27 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Vena caval filter |
US5601581A (en) * | 1995-05-19 | 1997-02-11 | General Surgical Innovations, Inc. | Methods and devices for blood vessel harvesting |
US5639274A (en) * | 1995-06-02 | 1997-06-17 | Fischell; Robert E. | Integrated catheter system for balloon angioplasty and stent delivery |
US6180059B1 (en) * | 1995-06-05 | 2001-01-30 | Therox, Inc. | Method for the preparation and delivery of gas-enriched fluids |
US5833650A (en) * | 1995-06-05 | 1998-11-10 | Percusurge, Inc. | Catheter apparatus and method for treating occluded vessels |
US5766203A (en) * | 1995-07-20 | 1998-06-16 | Intelliwire, Inc. | Sheath with expandable distal extremity and balloon catheters and stents for use therewith and method |
US5702373A (en) * | 1995-08-31 | 1997-12-30 | Target Therapeutics, Inc. | Composite super-elastic alloy braid reinforced catheter |
US6120477A (en) * | 1995-09-18 | 2000-09-19 | Gore Enterprise Holdings, Inc. | Balloon catheter device |
US5925016A (en) * | 1995-09-27 | 1999-07-20 | Xrt Corp. | Systems and methods for drug delivery including treating thrombosis by driving a drug or lytic agent through the thrombus by pressure |
US5653689A (en) * | 1995-09-30 | 1997-08-05 | Abacus Design & Development, Inc. | Infusion catheter |
US5669924A (en) * | 1995-10-26 | 1997-09-23 | Shaknovich; Alexander | Y-shuttle stent assembly for bifurcating vessels and method of using the same |
US6228052B1 (en) * | 1996-02-29 | 2001-05-08 | Medtronic Inc. | Dilator for introducer system having injection port |
US6176851B1 (en) * | 1996-05-14 | 2001-01-23 | Embol-X, Inc. | Cardioplegia occluder |
US6022336A (en) * | 1996-05-20 | 2000-02-08 | Percusurge, Inc. | Catheter system for emboli containment |
US5997557A (en) * | 1996-07-17 | 1999-12-07 | Embol-X, Inc. | Methods for aortic atherectomy |
US5895399A (en) * | 1996-07-17 | 1999-04-20 | Embol-X Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US6066158A (en) * | 1996-07-25 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot encasing and removal wire |
US5794629A (en) * | 1996-11-27 | 1998-08-18 | The Regents Of The University Of California | Method for treating ischemic brain stroke |
US5843027A (en) * | 1996-12-04 | 1998-12-01 | Cardiovascular Dynamics, Inc. | Balloon sheath |
US6295989B1 (en) * | 1997-02-06 | 2001-10-02 | Arteria Medical Science, Inc. | ICA angioplasty with cerebral protection |
US6135991A (en) * | 1997-03-06 | 2000-10-24 | Percusurge, Inc. | Aspiration method |
US6090096A (en) * | 1997-04-23 | 2000-07-18 | Heartport, Inc. | Antegrade cardioplegia catheter and method |
US5911734A (en) * | 1997-05-08 | 1999-06-15 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
US5910154A (en) * | 1997-05-08 | 1999-06-08 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment |
US6059745A (en) * | 1997-05-20 | 2000-05-09 | Gelbfish; Gary A. | Thrombectomy device and associated method |
US5919163A (en) * | 1997-07-14 | 1999-07-06 | Delcath Systems, Inc. | Catheter with slidable balloon |
US5941896A (en) * | 1997-09-08 | 1999-08-24 | Montefiore Hospital And Medical Center | Filter and method for trapping emboli during endovascular procedures |
US6013085A (en) * | 1997-11-07 | 2000-01-11 | Howard; John | Method for treating stenosis of the carotid artery |
US6238412B1 (en) * | 1997-11-12 | 2001-05-29 | William Dubrul | Biological passageway occlusion removal |
US5997503A (en) * | 1998-02-12 | 1999-12-07 | Ballard Medical Products | Catheter with distally distending balloon |
US6264631B1 (en) * | 1998-02-12 | 2001-07-24 | Ballard Medical Products | Catheter with distally distending balloon |
US6042559A (en) * | 1998-02-24 | 2000-03-28 | Innercool Therapies, Inc. | Insulated catheter for selective organ perfusion |
US6099497A (en) * | 1998-03-05 | 2000-08-08 | Scimed Life Systems, Inc. | Dilatation and stent delivery system for bifurcation lesions |
US6206868B1 (en) * | 1998-03-13 | 2001-03-27 | Arteria Medical Science, Inc. | Protective device and method against embolization during treatment of carotid artery disease |
US6413235B1 (en) * | 1998-03-13 | 2002-07-02 | Arteria Medical Science, Inc. | Protective device against embolization in carotid angioplasty |
US20020087119A1 (en) * | 1998-03-13 | 2002-07-04 | Arteria Medical Science, Inc. | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US6423032B2 (en) * | 1998-03-13 | 2002-07-23 | Arteria Medical Science, Inc. | Apparatus and methods for reducing embolization during treatment of carotid artery disease |
US6540712B1 (en) * | 1998-03-13 | 2003-04-01 | Arteria Medical Science, Inc. | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease |
US6379373B1 (en) * | 1998-08-14 | 2002-04-30 | Confluent Surgical, Inc. | Methods and apparatus for intraluminal deposition of hydrogels |
US6056720A (en) * | 1998-11-24 | 2000-05-02 | Embol-X, Inc. | Occlusion cannula and methods of use |
US6165199A (en) * | 1999-01-12 | 2000-12-26 | Coaxia, Inc. | Medical device for removing thromboembolic material from cerebral arteries and methods of use |
US6161547A (en) * | 1999-01-15 | 2000-12-19 | Coaxia, Inc. | Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use |
US6458139B1 (en) * | 1999-06-21 | 2002-10-01 | Endovascular Technologies, Inc. | Filter/emboli extractor for use in variable sized blood vessels |
US6221042B1 (en) * | 1999-09-17 | 2001-04-24 | Scimed Life Systems, Inc. | Balloon with reversed cones |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9345499B2 (en) | 2011-05-26 | 2016-05-24 | Covidien Lp | Pressure activated foreign body removal system and method of use |
US10682253B2 (en) | 2012-08-03 | 2020-06-16 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases |
US11654047B2 (en) | 2012-08-03 | 2023-05-23 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases |
US10342699B2 (en) | 2012-08-03 | 2019-07-09 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases |
US10751215B2 (en) | 2012-08-03 | 2020-08-25 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases |
US10470925B2 (en) | 2012-08-03 | 2019-11-12 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases |
US9597171B2 (en) | 2012-09-11 | 2017-03-21 | Covidien Lp | Retrieval catheter with expandable tip |
US10383644B2 (en) | 2013-10-17 | 2019-08-20 | Covidien Lp | Mechanical thrombectomy with proximal occlusion |
CN104688290A (en) * | 2013-12-07 | 2015-06-10 | 复旦大学附属妇产科医院 | Method for internal compression hemostasis after minimally invasive breast lump rotary varicotomy and hemostatic balloon |
CN106102654A (en) * | 2014-01-10 | 2016-11-09 | 企斯动哈特有限公司 | Dissect independent deflector |
US10758409B2 (en) | 2014-12-29 | 2020-09-01 | J.D. Franco & Co., Llc | Apparatus and method for treating eye diseases |
US10195077B2 (en) | 2016-03-09 | 2019-02-05 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases using retrograde blood flow |
US10143585B2 (en) | 2016-03-09 | 2018-12-04 | J.D. Franco & Co., Llc | Systems and methods for treating eye diseases using retrograde blood flow |
US9987164B2 (en) | 2016-03-09 | 2018-06-05 | J.D. Franco & Co. | Systems and method for treating eye diseases using retrograde blood flow |
US11690985B2 (en) | 2016-09-24 | 2023-07-04 | J.D. Franco & Co., Llc | Systems and methods for single puncture percutaneous reverse blood flow |
US11278389B2 (en) | 2016-12-08 | 2022-03-22 | J.D. Franco & Co., Llc | Methods and devices for treating an eye using a filter |
US11925339B2 (en) | 2017-01-25 | 2024-03-12 | J.D. Franco & Co., Llc | Blood vessel access and closure devices and related methods of use |
US11529130B2 (en) | 2017-01-25 | 2022-12-20 | J.D. Franco & Co., Llc | Blood vessel access and closure devices and related methods of use |
US10772645B2 (en) | 2017-05-07 | 2020-09-15 | J.D. Franco & Co., Llc | Devices and methods for treating an artery |
US10898212B2 (en) | 2017-05-07 | 2021-01-26 | J.D. Franco & Co., Llc | Devices and methods for treating an artery |
US11701255B2 (en) | 2017-10-06 | 2023-07-18 | J.D. Franco & Co., Llc | Treating eye diseases by deploying a stent |
US10779929B2 (en) | 2017-10-06 | 2020-09-22 | J.D. Franco & Co., Llc | Treating eye diseases by deploying a stent |
US10398880B2 (en) | 2017-11-02 | 2019-09-03 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
US11213659B2 (en) | 2017-11-02 | 2022-01-04 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
US10758254B2 (en) | 2017-12-15 | 2020-09-01 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
US11759218B2 (en) | 2017-12-15 | 2023-09-19 | J.D. Franco & Co., Llc | Medical systems, devices, and related methods |
US11478249B2 (en) | 2018-02-23 | 2022-10-25 | J.D. Franco & Co., Llc | Ophthalmic artery therapy under reverse flow |
US10765843B2 (en) | 2018-12-31 | 2020-09-08 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
US10933226B2 (en) | 2018-12-31 | 2021-03-02 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
US10814109B2 (en) | 2018-12-31 | 2020-10-27 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
US10799688B2 (en) | 2018-12-31 | 2020-10-13 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
US10792478B2 (en) | 2018-12-31 | 2020-10-06 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
US10695541B1 (en) | 2018-12-31 | 2020-06-30 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
US10668258B1 (en) | 2018-12-31 | 2020-06-02 | J.D. Franco & Co., Llc | Intravascular devices, systems, and methods to address eye disorders |
CN111248964A (en) * | 2020-01-16 | 2020-06-09 | 张跃国 | Cardiovascular internal medicine intervention device |
WO2021170267A1 (en) | 2020-02-25 | 2021-09-02 | Free Life Medical Gmbh | System for supplying and removing blood, and assembly method |
DE102020202401A1 (en) | 2020-02-25 | 2021-08-26 | Free Life Medical Gmbh | System for supplying and withdrawing blood and assembly process |
Also Published As
Publication number | Publication date |
---|---|
US7927347B2 (en) | 2011-04-19 |
AU2003224695A1 (en) | 2003-09-29 |
WO2003077983A1 (en) | 2003-09-25 |
US20050228432A1 (en) | 2005-10-13 |
US6908474B2 (en) | 2005-06-21 |
US20020173815A1 (en) | 2002-11-21 |
US20100204724A1 (en) | 2010-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7927347B2 (en) | Apparatus and methods for reducing embolization during treatment of carotid artery disease | |
US6905490B2 (en) | Apparatus and methods for reducing embolization during treatment of carotid artery disease | |
US6540712B1 (en) | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease | |
CA2380350C (en) | Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease | |
US20050131453A1 (en) | Apparatus and methods for reducing embolization during treatment of carotid artery disease | |
US6582396B1 (en) | Puncture resistant balloon for use in carotid artery procedures and methods of use | |
US6206868B1 (en) | Protective device and method against embolization during treatment of carotid artery disease | |
US6645222B1 (en) | Puncture resistant branch artery occlusion device and methods of use | |
US6929634B2 (en) | Apparatus and methods for treating stroke and controlling cerebral flow characteristics | |
US6994718B2 (en) | Distal protection device for filtering and occlusion | |
US6454741B1 (en) | Aspiration method | |
US20120172967A1 (en) | Embolic protection systems for bifurcated conduits | |
AU2008229661B2 (en) | Apparatus for removing emboli during an angioplasty or stenting procedure | |
JP2011087971A (en) | Method and low profile apparatus for reducing embolization during treatment of carotid artery disease | |
AU2005202496B2 (en) | Apparatus for removing emboli during an angioplasty or stenting procedure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: W. L. GORE & ASSOCIATES, INC., DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GORE ENTERPRISE HOLDINGS, INC.;REEL/FRAME:027906/0508 Effective date: 20120130 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |